Control of the master virulence regulatory gene atxA in Bacillus anthracis by Dale, Jennifer L
Texas Medical Center Library
DigitalCommons@The Texas Medical Center
UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences
5-2012
Control of the master virulence regulatory gene
atxA in Bacillus anthracis
Jennifer L. Dale
Follow this and additional works at: http://digitalcommons.library.tmc.edu/utgsbs_dissertations
Part of the Pathogenic Microbiology Commons
This Dissertation (PhD) is brought to you for free and open access by the
Graduate School of Biomedical Sciences at DigitalCommons@The Texas
Medical Center. It has been accepted for inclusion in UT GSBS
Dissertations and Theses (Open Access) by an authorized administrator of
DigitalCommons@The Texas Medical Center. For more information,
please contact laurel.sanders@library.tmc.edu.
Recommended Citation
Dale, Jennifer L., "Control of the master virulence regulatory gene atxA in Bacillus anthracis" (2012). UT GSBS Dissertations and
Theses (Open Access). Paper 259.
CONTROL OF THE MASTER VIRULENCE REGULATORY                                               
GENE ATXA IN BACILLUS ANTHRACIS 
 by 
Jennifer Lynn Dale, B.S.  
 
 
APPROVED: 
 
 
 
______________________________ 
Supervisory Professor 
Theresa M. Koehler, Ph.D. 
 
 
 
______________________________ 
William Margolin, Ph.D. 
 
 
 
______________________________ 
Peter J. Christie, Ph.D. 
 
 
 
______________________________ 
Ambro van Hoof, Ph.D. 
 
 
 
______________________________ 
Michael R. Blackburn, Ph.D. 
 
APPROVED: 
 
 
 
____________________________ 
Dean, The University of Texas 
Health Science Center at Houston 
Graduate School of Biomedical Sciences 
 
 ii 
CONTROL OF THE MASTER VIRULENCE REGULATORY 
GENE ATXA IN BACILLUS ANTHRACIS 
 
A 
Dissertation 
 
Presented to the Faculty of 
The University of Texas 
Health Science Center at Houston 
Graduate School of Biomedical Sciences 
and  
The University of Texas 
M.D. Anderson Cancer Center 
Graduate School of Biomedical Sciences 
in Partial Fulfillment 
of the Requirements 
for the Degree of  
DOCTOR OF PHILOSOPHY 
 
By 
Jennifer Lynn Dale, B.S. 
Houston, TX 
May, 2012 
 iii 
Acknowledgements 
 I would like to thank the Koehler lab members for insightful comments and helpful 
discussions.  I would especially like to acknowledge Maureen Ty, who assisted me in 
performing experiments related to Chapter IV, and Malik Raynor, who performed the animal 
injections related to Chapter V. 
 I also want to thank my committee members Peter J. Christie, Ph.D., William 
Margolin, Ph.D., Ambro van Hoof, Ph.D., and Michael R. Blackburn, Ph.D., for their 
guidance and support.  In addition, I would like to thank the Microbiology and Molecular 
Genetics Department faculty, staff, and students for their advice and assistance.  
Specifically, I would like to thank Caná Ross, Ph.D., Maria Hadjifrangiskou, Ph.D., Troy 
Hammerstrom, and Jesus Eraso, Ph.D., for insightful conversations. 
 I am grateful to my high school science teacher John Haug for introducing me to, 
and getting me interested in, microbiology.  He enabled me as a high school student to 
pursue my interests in microbiology by having me participate in extracurricular research and 
science fairs. 
 Finally, I would like to thank my graduate advisor and mentor, Theresa M. Koehler, 
Ph.D., for her constant encouragement and guidance.  She pushed me with her high 
expectations to become a better scientist, writer, and communicator.  The lessons I learned 
while being mentored by her will continually help shape my future scientific career. 
 
 
 
 
 
 
 iv 
CONTROL OF THE MASTER VIRULENCE REGULATORY  
GENE ATXA IN BACILLUS ANTHRACIS 
Publication No.________ 
 
Jennifer Lynn Dale, B.S.  
 
Supervisory Professor: Theresa M. Koehler, Ph.D. 
  
 Transcription of the Bacillus anthracis structural genes for the anthrax toxin proteins 
and biosynthetic operon for capsule are positively regulated by AtxA, a transcription 
regulator with unique properties. Consistent with the role of atxA in virulence factor 
expression, a B. anthracis atxA-null mutant is avirulent in a murine model for anthrax. In 
batch culture, multiple signals impact atxA transcript levels, and the timing and steady state 
level of atxA expression is critical for optimal toxin and capsule synthesis.  Despite the 
apparent complex control of atxA transcription, only one trans-acting protein, the transition 
state regulator AbrB, has been demonstrated to directly interact with the atxA promoter. 
The AbrB-binding site has been described, but additional cis-acting control sequences have 
not been defined. Using transcriptional lacZ fusions, electrophoretic mobility shift assays, 
and Western blot analysis, the cis-acting elements and trans-acting factors involved in 
regulation of atxA in B. anthracis strains containing either both virulence plasmids, pXO1 
and pXO2, or only one plasmid, pXO1, were studied.  This work demonstrates that atxA 
transcription from the major start site P1 is dependent upon a consensus sequence for the 
housekeeping sigma factor SigA, and an A+T-rich upstream element (UP-element) for RNA 
polymerase (RNAP).  In addition, the data show that a trans-acting protein(s) other than 
AbrB negatively impacts atxA transcription when it binds specifically to a 9-bp palindrome 
within atxA promoter sequences located downstream of P1.  Mutation of the palindrome 
 v 
prevents binding of the trans-acting protein(s) and results in a corresponding increase in 
AtxA and anthrax toxin production in a strain- and culture-dependent manner. 
 The identity of the trans-acting repressor protein(s) remains elusive; however, 
phenotypes associated with mutation of the repressor binding site have revealed that the 
trans-acting repressor protein(s) indirectly controls B. anthracis development.  Mutation of 
the repressor binding site results in misregulation and overexpression of AtxA in conditions 
conducive for development, leading to a marked sporulation defect that is both atxA- and 
pXO2-61-dependent.  pXO2-61 is homologous to the sensor domain of sporulation sensor 
histidine kinases and is proposed to titrate an activating signal away from the sporulation 
phosphorelay when overexpressed by AtxA.  These results indicate that AtxA is not only a 
master virulence regulator, but also a modulator of proper B. anthracis development.  Also 
demonstrated in this work is the impact of the developmental regulators AbrB, Spo0A, and 
SigH on atxA expression and anthrax toxin production in a genetically incomplete (pXO1+, 
pXO2-) and genetically complete (pXO1+, pXO2+) strain background.  AtxA and anthrax 
toxin production resulting from deletion of the developmental regulators are strain-
dependent suggesting that factors on pXO2 are involved in control of atxA.  The only 
developmental deletion mutant that resulted in a prominent and consistent strain-
independent increase in AtxA protein levels was an abrB-null mutant.  As a result of 
increased AtxA levels, there is early and increased production of anthrax toxins in an abrB-
null mutant.  In addition, the abrB-null mutant exhibited an increase in virulence in a murine 
model for anthrax.  In contrast, virulence of the atxA promoter mutant was unaffected in a 
murine model for anthrax despite the production of 5-fold more AtxA than the abrB-null 
mutant.  These results imply that AtxA is not the only factor impacting pathogenesis in an 
abrB-null mutant.  Overall, this work highlights the complex regulatory network that governs 
expression of atxA and provides an additional role for AtxA in B. anthracis development.  
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1.1. Physiology of the Bacillus cereus group members  
 The Bacillus cereus group, also referred to as “group 1 bacilli” or “Bacillus cereus 
sensu lato”, contains six related Bacillus species: Bacillus anthracis, Bacillus thuringiensis, 
Bacillus cereus sensu stricto, Bacillus weihenstephanensis, Bacillus mycoides, and Bacillus 
pseudomycoides.  These species are rod-shaped, Gram-positive aerobic or facultatively 
anaerobic developmental bacteria that can form endospores in response to nutrient 
deprivation (Fig. 1-1).  Bacillus spores are resistant to environmental stresses such as 
desiccation, heat, UV light, and chemicals enabling persistence of the organism (88).  The 
Bacillus species are saprophytic organisms growing under nutrient rich conditions including 
some soil environments, and are common inhabitants of the gut of invertebrates (81).      
 The most well studied members of the B. cereus group, B. anthracis, B. cereus 
sensu stricto, and B. thuringiensis, are pathogens with common and unique properties that 
facilitate disease.  B. anthracis is the etiological agent of anthrax disease while B. cereus 
sensu stricto and B. thuringiensis are opportunistic human pathogens causing mild food 
poisoning.  B. cereus sensu stricto and B. thuringiensis can also cause local and systemic 
hospital-acquired infections; however, these diseases are less common.  Even though B. 
thuringiensis can cause opportunistic human infections, it is considered primarily to be a 
pathogen of insects. 
 The B. cereus group members are closely related in chromosomal gene content and 
synteny (73, 123).  Distinguishing characteristics between the species are often attributed 
to the presence or absence of virulence-associated plasmids.  B. anthracis contains two 
extrachromosomal virulence plasmids, pXO1 and pXO2.  The structural genes for anthrax 
toxin, pagA (PA), cya (EF), and lef (LF) are located on pXO1 (84) while the capsule 
biosynthetic operon, capBCADE, is located on pXO2 (27, 97, 112).  The B. cereus sensu 
stricto cereulide (emetic toxin) synthesis genes are located on a pXO1-like plasmid  
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Figure 1-1. Phase micrograph of a sporulating B. anthracis culture.  Vegetative cells 
(left panel) replicate and divide until nutrients are scarce at which point they form 
endospores (middle panel) and finally release fully developed spores (right panel) from the 
mother cell.  
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(46, 47, 88, 96, 143), and the B. thuringiensis insecticidal toxin genes are located on large, 
transmissible plasmids (123).  Lack of virulence plasmids typically attenuates B. cereus 
group members with the exception of B. cereus sensu stricto isolates that produce 
chromosome-encoded enterotoxins (143).    
 The growth temperature and local environment of each B. cereus group member 
species correlates with the conditions required for optimal virulence factor production.  
Psychrotolerant species such as B. cereus sensu stricto synthesizes maximal amounts of 
cereulide (emetic toxin) when cultured between 12-22°C (49).  Growth of B. cereus sensu 
stricto, and likely select isolates of B. thuringiensis, at 37°C in low oxydoreduction 
anaerobic environments such as those in the small intestines, enhances production of 
enterotoxins (45).  B. anthracis produces its virulence factors, anthrax toxin and capsule, 
when cultured at 37°C in a minimal medium containing dissolved bicarbonate and elevated 
atmospheric CO2, conditions relevant for pathogenesis (9, 10, 29, 145, 161).  B. 
thuringiensis produces its insecticidal pro-toxin crystalline aggregates in sporulating mother 
cells that are released at the completion of sporulation.    
 
1.2. Sporulation of the Bacillus genus  
 With most infections caused by B. cereus group members, the spore constitutes the 
infectious form of the organism.  Members of the Bacillus genus undergo a developmental 
process that results in vegetative cells differentiating into dormant spores.  This process of 
development, referred to as sporulation, has been best-characterized in B. subtilis, the 
archetype Bacillus species.  B. subtilis, like the B. cereus group members, is a soil 
bacterium that senses and responds to environmental stimuli.  In nutrient deprived 
conditions, B. subtilis senses the lack of nutrients and initiates sporulation.  Sporulation is 
considered the last resort for Bacillus species survival since the developmental process is 
energy exhaustive.  When cultured in the laboratory, sporogenous strains will initiate 
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sporulation during the transition from exponential to stationary phase of growth.  Multiple 
pleiotropic regulators are part of the developmental process involved in spore formation and 
have been termed transition-state regulators.  The most important of these transition-state 
regulators is AbrB. 
 The primary role of transition-state regulators such as AbrB is to prevent the 
inappropriate expression of genes whose functions are only needed during stationary 
phase of growth.  Several of these stationary phase-specific genes are required for 
sporulation initiation and are repressed during exponential growth by AbrB to prevent 
premature sporulation initiation.  AbrB is a DNA-binding protein that directly binds to the 
promoter region of over 40 different B. subtilis genes.  Examination of AbrB-controlled 
promoter regions has not revealed a consensus sequence, which suggests AbrB binds its 
target promoters based on DNA structure (148-150, 154, 178, 179).  The threshold AbrB 
concentration required for repressing sporulation genes has a narrow range.  AbrB 
autoregulates its own expression during exponential growth. As cells transition into 
stationary phase abrB is repressed leading to a drop in AbrB concentrations below the 
effective range.  This repression of abrB transcription at the transition into stationary phase 
is attributed to the master response regulator Spo0A (121, 147, 153).   
 Upon nutrient limitation, a multi-component signal transduction phosphorelay is 
initiated which leads to the phosphorylation and activation of Spo0A (22).  In B. subtilis, the 
phosphorelay contains a number of sensor histidine kinases, phosphorylated response 
regulators, and phosphatases (Fig. 1-2).  Spo0A is the master response regulator that is 
capable of both activating and repressing genes required for sporulation initiation by 
binding to its cognate ‘0A box’ (107, 144, 147, 152).  One of the crucial roles of Spo0A~P is 
to repress abrB transcription, relieving repression of post-exponential sporulation genes.  
 In order for Spo0A to become phosphorylated, cells must sense the depletion of 
nutrients and trigger activation of the phosphorelay by enabling autophosphorylation of   
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Figure 1-2. Multi-component signal transduction sporulation phosphorelay.  See text 
for details. B. subtilis specific proteins are depicted by gray lettering.  B. anthracis proteins 
are depicted in black below the gray lettered B. subtilis protein orthologues. The response 
regulators Spo0F, Spo0B, and Spo0A, and the developmental regulators SigH and AbrB 
are present in both B. anthracis and B. subtilis. 
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sensor histidine kinases (KinA, KinB, KinC, KinD, and/or KinE).  The exact signal for 
induction is unknown.  The activating phosphoryl group is transferred from the sensor 
histidine kinase to the intermediate response regulator Spo0F.  Using the 
phosphotransferase protein Spo0B, the phosphoryl group is transferred from Spo0F to 
Spo0A.  The use of Spo0F and Spo0B as response regulator intermediates provides an 
additional level of regulation of the phosphorelay.   
Other controls of the phosphorelay include phosphatases and positive feedback 
loops.  Members of the Rap family of phosphatases (RapA, RapB, and RapE) 
dephosphorylate Spo0A~P indirectly by removing the phosphoryl group from Spo0F, 
whereas Spo0A~P is directly dephosphorylated by the Spo0E family of phosphatases 
(Spo0E, YisI, and YnzD) (82, 111, 117, 118).  Spo0A~P levels continue to increase as a 
result of a feedback loop including AbrB and the alternative sigma factor SigH (150, 155).  
Transcription of sigH is repressed by AbrB; therefore, Spo0A~P repression of abrB leads to 
increased levels of SigH (148, 171).  The spo0A and spo0F genes contain SigH-controlled 
promoters that are activated to increase expression of these two phosphorelay response 
regulators.  Spo0A~P further activates, directly and indirectly, all the necessary genes 
required for the subsequent cascade of events which ultimately leads to complete 
development of B. subtilis and release of the endospore from the mother cell (reviewed in 
(121)).    
 Components of the sporulation phosphorelay are conserved among B. cereus group 
members most likely resulting in similar control of sporulation initiation among species.  Of 
particular interest to researchers investigating sporulation in B. cereus group members is 
the etiological agent of anthrax disease, B. anthracis.  Orthologues of Spo0F, Spo0B and 
Spo0A were identified in B. anthracis (144).  In addition, five sensor histidine kinases 
(BA4223, BA2291, BA1351, BA1356 and BA5029) were identified in B. anthracis based on 
the amino acid conservation surrounding the active-site histidine of the major B. subtilis 
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sensor histidine kinase, KinA.  The B. anthracis sensor histidine kinases were determined 
to be functional using a series of genetic deletion and complementation assays (21).  
Negative regulation of the phosphorelay involves the production of Spo0F- and Spo0A-
specific phosphatases, Raps and Spo0E-like proteins, respectively.  Two Rap 
phosphatases, one chromosome-encoded (BA3790) and the other pXO1-encoded 
(BXA0205), identified in B. anthracis were capable of directly dephosphorylating Spo0F.  
When overexpressed, the Rap phosphatases negatively impacted sporulation (16).  Spo0A 
is directly dephosphorylated by the Spo0E-family of proteins.  B. anthracis contains four 
genes that are homologues to the B. subtilis Spo0E, two (BA1877 and BA2416) of which 
were readily expressed in B. anthracis and shown to actively inhibit sporulation (15).   
 A unique attribute of B. anthracis is the expression of two plasmid-encoded proteins 
(pXO1-118 and pXO2-61) that also affect sporulation.  When overexpressed, pXO2-61, and 
to a lesser extent pXO1-118, decrease sporulation efficiency.  These proteins bear 
homology to the signal sensor domain of the B. anthracis sensor histidine kinase BA2291.  
It has been proposed that overexpression of pXO2-61 titrates a signal away from BA2291 
which results in BA2291 conversion to a phosphatase specific for Spo0F (174).  The 
presence of these plasmid-associated sporulation inhibitors suggest that B. anthracis has 
developed additional control mechanisms of the phosphorelay enabling adaptation to 
growth within a host where sporulation does not occur.  
 
1.3. Bacillus anthracis and anthrax disease 
 As the etiological agent of anthrax disease, B. anthracis is the most renowned 
member of the B. cereus group.  B. anthracis infection results in one of three forms of 
anthrax disease: cutaneous, gastrointestinal, or inhalation.  The specific type of anthrax 
disease depends on the route of entry of the B. anthracis spore.  Cutaneous anthrax is the 
most commonly reported of the three diseases and results from entry of spores into cuts or 
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abrasion in the skin.  If recognized and treated properly, cutaneous anthrax is rarely fatal.  
The rarest form of anthrax, gastrointestinal anthrax, results from ingestion of spores.  It is 
difficult to diagnose gastrointestinal anthrax; therefore, the lack of early recognition and 
treatment often leads to a lethal outcome.  Inhalation anthrax is the most well-known and 
well-studied form of disease.  Spores enter the lungs where they are phagocytosed by 
resident macrophages and dendritic cells which transfer the spores to regional lymph nodes 
enabling the spores to germinate and disseminate (8, 34, 39, 106, 128).  Initial nonspecific 
flu-like symptoms of inhalation anthrax result in difficult diagnosis of disease.  If untreated, 
inhalation anthrax progresses to full respiratory distress, septicemia, shock and eventually 
death.  Inhalation anthrax is nearly always fatal. 
 B. anthracis can evade and escape the host immune response primarily by 
production of anthrax toxin and a poly-γ-D-glutamic acid capsule.  Anthrax toxin is arguably 
the most important virulence factor produced by B. anthracis. The toxin is comprised of 
three pXO1-encoded proteins: protective antigen (PA), lethal factor (LF) and edema factor 
(EF).  Binary combination of PA and LF is termed “lethal toxin” (LT) and combination of PA 
and EF is termed “edema toxin” (ET).  Anthrax toxin entry is initiated when PA (85 kDa) 
binds to host cells via specific receptors (ANTXR1 and ANTXR2), is cleaved by a furin-like 
protease, and forms a multimeric prepore that is capable of binding LF (83 kDa) and/or EF 
(89 kDa). Upon endocytosis of the protein-receptor complex and endosomal acidification, 
the PA prepore undergoes a conformational change enabling insertion into the endosomal 
membrane and translocation of LT and ET into the host cell cytosol (13, 51, 89, 104, 157, 
180).  LF is a zinc-dependent metalloprotease that inhibits the MAPK signal transduction 
pathway ultimately resulting in host cell death (44, 86, 163).  EF is a calmodulin-dependent 
adenylyl cyclase that elevates cellular levels of cAMP causing host cell edema (90, 163). 
 As is true for most bacteria that produce a capsule, the B. anthracis capsule is anti-
phagocytic and associated with dissemination during infection (42, 57, 83, 97, 116).  The B. 
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anthracis capsule composition is unique from other bacteria.  Instead of producing a 
polysaccharide capsule like most bacteria, the B. anthracis capsule is composed solely of 
D-glutamic acid residues that are gamma-linked to form homopolymers (125).  
Encapsulated B. anthracis is likely protected from the destructive response of host cells 
because of its anti-immunogenic properties.   
 
1.4. Major pleiotropic regulators in the Bacillus cereus group members 
Virulence factor production is coordinately controlled in B. cereus group members in 
response to specific signals and regulators.  In B. anthracis, the master virulence regulator 
AtxA (anthrax toxin activator) controls expression of the anthrax toxins and poly-γ-D-
glutamic acid capsule (18).  B. cereus sensu stricto and B. thuringiensis rely on the 
pleiotropic transcriptional regulator PlcR to control expression of their virulence factors (1, 
59, 91).  Differential gene expression among the B. cereus group species can be attributed 
in part to PlcR- and AtxA-controlled activities in these species. 
The atxA gene is located on the B. anthracis virulence plasmid pXO1 (87, 165).  The 
AtxA regulon includes B. anthracis-specific structural genes for anthrax toxin, pagA, cya, 
and lef, located on pXO1, and the capsule biosynthetic operon, capBCADE, located on 
pXO2.  In addition, AtxA controls some chromosomal genes common to B. cereus sensu 
stricto and B. thuringiensis (18).  Typical B. cereus sensu stricto and B. thuringiensis strains 
do not carry the plasmid harboring atxA and therefore exhibit differential expression of 
AtxA-controlled chromosomal genes. 
The global regulator in B. cereus sensu stricto and B. thuringiensis species, PlcR, is 
encoded by the chromosome and controls expression of several genes, many associated 
with pathogenesis (1, 59, 91).  The plcR gene in B. anthracis contains a strain-specific 
nonsense mutation that results in a truncated, non-functional protein (102).  B. anthracis 
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carries multiple PlcR targets, but the lack of a functional PlcR results in minimal or no 
expression of these genes (127).   
Interestingly, expression of a B. thuringiensis plcR gene in a B. anthracis strain 
containing atxA resulted in a significant decrease in sporulation, a phenotype that was 
rescued by deletion of atxA.  It has been proposed that the plcR and atxA regulons in B. 
anthracis are not compatible and that the nonsense mutation within the B. anthracis plcR 
gene provided a selective advantage for evolution of the species (102). Nevertheless, 
recent reports of unusual B. cereus sensu stricto strains suggest that in certain strain 
backgrounds PlcR and AtxA can coexist.  B. cereus G9241, which causes an anthrax-like 
disease, carries plcR and atxA genes and expresses factors attributed to both regulons 
(78).  
 
1.5. PlcR: A pleiotropic regulator in Bacillus cereus sensu stricto and Bacillus 
thuringiensis 
 The pleiotropic transcriptional regulator PlcR, initially discovered as a positive 
regulator of the phospholipase C gene in B. thuringiensis (91), controls multiple genes 
encoding secreted toxins and degradative enzymes, cell wall associated proteins, and 
cytoplasmic regulatory proteins in B. thuringiensis and B. cereus sensu stricto  (1, 59, 91).  
PlcR regulation is not apparent in B. anthracis because the plcR locus contains a nonsense 
mutation resulting in a truncated nonfunctional protein (1, 102, 140). Proteomic studies, 
transcriptional profiling, and in silico analyses have been employed to determine PlcR 
regulons in several B. thuringiensis and B. cereus sensu stricto strains (1, 59, 60, 114).  
Established PlcR-controlled virulence genes include enterotoxins, hemolysins, proteases 
and phospholipases. These genes are spread throughout the genome and do not form 
pathogenic islands on the chromosome (1).  
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 The 34-kDa PlcR protein contains an amino-terminal helix-turn-helix DNA-binding 
domain and a carboxy-terminal regulatory domain consisting of 11 helices that form five 
tetratricopeptide repeats (TPR) (37). PlcR activity is dependent upon interaction with the 
quorum-sensing peptide PapR (peptide activating PlcR) (138). In the current model for 
PlcR/PapR function (Fig. 1-3A), PapR is synthesized as a 48-amino acid peptide and 
secreted by the SecA machinery.  Once outside of the cell, PapR is proteolytically 
processed to a heptapeptide that is imported into the cell via the OppABCDF transport 
system (17, 61). Inside the cell, the PapR heptapeptide associates with PlcR to activate 
target genes. The crystal structure of PlcR:PapR indicates that PapR binds to the concave 
side of PlcR TPR domain helices 5 and 7 triggering dimerization of two PlcR:PapR 
complexes via the TPR domains (37).   
 The plcR/papR genes form a bicistronic cluster that is autogenously controlled (1, 
91) and B. cereus group members can be classified into four distinct groups based on the 
sequence and specificity of the PlcR:PapR pair.  PlcR groups I, II, III and IV are associated 
with PapR heptapeptides including the carboxy-terminal sequences LPFE(F/Y), 
VP(F/Y)E(F/Y), MPFEF, and LPFEH, respectively  (17, 139). The first and last amino acids 
of these peptide sequences determine specificity of PlcR:PapR for its target genes (17, 
138, 139).  The PlcR:PapR complex binds to a consensus DNA sequence, the palindromic 
‘PlcR box’ (TATGNAN4TNCATA), located up to 200 nucleotides upstream of the -10 box of 
a promoter region (1, 114). In silico and genetic analyses have revealed variability in PlcR 
box sequences. The A+T-content is higher in the vicinity of PlcR boxes that are active when 
grown in rich conditions [Luria-Bertani broth (LB), 30°C] (59). PlcR-target genes typically 
contain promoter regions that resemble the canonical -10 region of the housekeeping sigma 
factor, SigA, and a -35 recognition region that is slightly different than the typical SigA 
consensus sequence (1, 59).  
 plcR transcription is controlled by the developmental regulator Spo0A. Two Spo0A 
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Figure 1-3. Models for AtxA and PlcR control of virulence gene expression. (A) plcR 
gene activation and PlcR:PapR function in B. cereus group members. Signals that impact 
plcR/papR transcription include nutritional status and cell density. The master response 
regulator Spo0A binds directly to the plcR promoter to repress transcription. PlcR contains 
a DNA-binding domain, HTH, and tetratricopeptide repeats, TPRs, that regulate activity. 
PapR is exported by the SecA machinery, proteolytically processed to a heptapeptide, and 
imported into the cell by the OppABCDF transport system. Mature processed PapR 
associates with PlcR enabling dimerization and regulation of activity. The PlcR:PapR 
complex autogenously controls the plcR/papR bicistronic gene cluster in addition to multiple 
genes encoding secreted toxins and degradative enzymes, cell wall associated proteins, 
and cytoplasmic regulatory proteins. (B) atxA gene activation and AtxA function in B. 
anthracis. Multiple signals including growth phase, redox potential, temperature and 
carbohydrate availability impact the transcription of atxA. The growth phase transition state 
regulator AbrB binds directly to the atxA promoter region to repress transcription. Predicted 
functional domains of AtxA are: winged helix (WH) and helix-turn-helix (HTH) for DNA 
binding; PEP:sugar dependent phosphotransferase system (PTS) domains (PRD1 and 
PRD2), for regulation of activity; and enzyme IIB component of the PTS (EIIB), for 
multimerization. In the presence of elevated CO2/bicarbonate, AtxA positively affects 
transcription of the anthrax toxin genes and the biosynthetic operon for synthesis of poly-D-
glutamic acid (PDGA) capsule.  
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boxes flank the ‘PlcR box’ upstream of plcR.  Active phosphorylated Spo0A is thought to 
repress plcR transcription by competing with PlcR:PapR for binding to the plcR promoter 
region (92).  During batch culture in rich media, transcription of plcR and PlcR-regulated 
genes increases at the transition from exponential to stationary phase of growth. When 
cells are cultured in sporulation media, phosphorylated Spo0A prevents plcR activation 
(92).  Thus, elevated plcR transcription occurs when the nutrient status keeps Spo0A~P 
levels low, and when cells are at a high density due to quorum-sensing (59, 92). 
 Deletion of plcR in pathogenic B. cereus sensu stricto and B. thuringiensis strains 
decreases virulence in insect larvae, mice, and rabbit eye models (25, 132, 138).  A 
majority of strains synthesize a functional PlcR protein, but a small proportion (1%) contain 
plcR or papR genes with mutations rendering non-functional proteins. B. anthracis harbors 
multiple orthologues of plcR-regulated genes, but does not contain a functional PlcR due to 
a point mutation in plcR that results in a truncated protein (1, 140). Introduction of a 
functional B. thuringiensis-derived PlcR into B. anthracis facilitates expression of genes with 
PlcR boxes in their promoter regions, including genes encoding proteases, hemolysins and 
phospholipases.  However, increased expression of these PlcR-regulated virulence factors 
did not influence the virulence of B. anthracis in a murine model of anthrax infection (102).   
 
1.6. AtxA: A unique regulator in Bacillus anthracis  
 The atxA gene, initially named for its involvement in anthrax toxin gene activation, 
encodes a master virulence regulator of the anthrax toxin genes pagA, lef, and cya.  atxA is 
located on the virulence plasmid pXO1 within a 45-kb pathogenicity island that includes the 
structural genes for anthrax toxin (103, 112).  The capsule biosynthetic operon, capBCADE, 
and the capsule gene regulator acpA, both located on pXO2, are also positively controlled 
at the transcriptional level by AtxA (36, 40, 50, 67, 87, 101, 136, 165, 166).  Transcriptional 
profiling and other experiments have revealed over 100 additional atxA-regulated genes 
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located on pXO1, pXO2, and the chromosome (18, 75, 77).  A B. anthracis atxA-null strain 
is avirulent in a murine anthrax model demonstrating the necessity of AtxA for virulence 
(36). 
 The molecular mechanism by which AtxA regulates its target genes is unknown.  
AtxA has an apparent molecular weight of 55.6 kDa and motifs suggestive of DNA-binding 
and regulation of activity.  Analysis of the AtxA amino acid sequence reveals two putative 
DNA-binding motifs, a winged-helix (WH) and helix-turn-helix (HTH), near the amino-
terminus.  However, no specific DNA-binding activity has been shown.  Located near the 
center and carboxy-terminus are regions similar to proteins involved in the 
phosphoenolpyruvate:carbohydrate phosphotransferase system (PTS) (70, 164).  These 
regions are predicted to regulate AtxA activity.  Two putative PTS regulation domains 
(PRD1 and PRD2) are located near the center of AtxA.  PRDs are common to 
transcriptional regulators that control genes associated with carbohydrate metabolism.  
Phosphorylation of specific histidine residues within PRDs affect protein oligomerization 
and function (38).  Two sites of phosphorylation were identified within the putative PRDs of 
AtxA.  Phosphorylation of H199 in PRD1 increased AtxA activity whereas phosphorylation 
of H379 in PRD2 decreased the activity of AtxA (164).  The carboxy-terminus contains a 
motif similar to the enzyme IIB (EIIB) component of the PTS.  EIIB proteins function in the 
PTS to phosphorylate incoming carbohydrates as they pass through their cognate EIIC 
permeases (38).  The EIIB domain of AtxA was shown to facilitate AtxA multimerization.  
Elevated AtxA activity has been attributed to multimerization of the protein (70).  
 Transcription of the toxin genes, capsule biosynthetic operon, and many other AtxA-
controlled genes is enhanced when cultured in the presence of elevated atmospheric CO2 
and 0.8% dissolved bicarbonate, conditions considered physiologically relevant for 
pathogenesis (Fig. 1-4) (9, 18, 28, 33, 36, 50, 75, 77, 87, 101, 137).  The monocistronic 
transcripts of the cya and lef genes map to single start sites and transcription of both genes 
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is atxA-dependent. The pagA gene is part of a bicistronic operon, pagApagR, which 
contains two transcription start sites (76).  The major start site (P1) is atxA-dependent while 
the minor start site (P2) is expressed constitutively at a relatively low level (36, 87).  AtxA 
positively affects transcription of the cap operon via control of the pXO2-encoded capsule 
regulators acpA and acpB (40, 67, 166, 169). The monocistronic transcripts of acpA map to 
two apparent transcription start sites; one start site (P1) is constitutively activate at a low 
level while the other (P2) is atxA-dependent.  The acpB gene can be transcribed from its 
own promoter as a monocistronic transcript, or as part of a multi-cistronic transcript with the 
cap operon via transcriptional read-through.  The cap operon contains three apparent 
transcription start sites; one start site (P3) is constitutively active at a relatively low level 
while the two other start sites (P1 and P2) are atxA-dependent.  Co-transcription of the cap 
operon and acpB creates a positive feedback loop for capBCADE transcription (41, 166).  
Nucleotide sequence similarities in promoter regions of atxA-regulated genes are not 
apparent.  It has been suggested that DNA curvature plays a role in AtxA regulation of its 
target toxin and capsule genes (69).                  
  The steady state level of AtxA does not appear to be significantly affected by 
CO2/bicarbonate; however, multiple signals impact the transcription of atxA (Fig. 1-3B).  In 
batch culture, atxA is expressed at relatively low levels during early exponential growth and 
expression peaks as the cells transition into stationary phase of growth (131).  This growth 
phase dependent control of atxA expression is attributed to the transition state regulator 
AbrB.  atxA expression is increased in an abrB-null mutant (131).  AbrB is a DNA-binding 
pleiotropic regulator, often a repressor, which controls a plethora of post-exponential phase 
genes during logarithmic growth.  Repression of genes by AbrB is relieved as cells 
transition into stationary phase (121, 151).  AbrB is the only trans-acting factor which has 
been shown to directly and specifically bind the atxA promoter region (151).  In the 
archetype Bacillus species, B. subtilis, AbrB is part of a feedback loop of regulators which 
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Figure 1-4. Anthrax toxin and capsule gene regulation.  See text for details.  The 
anthrax toxin genes, cya, pagAR, and lef, are located on the virulence plasmid pXO1.  The 
cap operon, capBCADE, and capsule gene regulators acpA and acpB are located on the 
virulence plasmid pXO2.  atxA-dependent promoters are shown in green.  Constitutively 
active promoters are depicted in black.  
 
 
 
 
 
 
 19 
include the master response regulator Spo0A and the alternative sigma factor SigH.  In B. 
anthracis, atxA expression is positively controlled by another component of the feedback 
loop, SigH, in a strain-dependent and AbrB-independent manner (14, 68).  Transcription of 
atxA is also increased during early exponential growth in small c-type cytochrome mutants.  
The small c-type cytochromes were shown to indirectly repress atxA when cultured in the 
absence of elevated CO2/bicarbonate; however, addition of CO2/bicarbonate eliminated the 
increased atxA expression phenotype making the importance of c-type cytochromes in 
pathogenesis unlikely (175). 
 Other signals impacting atxA transcription and AtxA protein levels are temperature 
and carbohydrate availability.  In agreement with the requirement of AtxA for B. anthracis 
pathogenesis, optimal expression of atxA occurs at 37°C (35).  Glucose is an additional 
signal impacting atxA transcription.  Regulation of transcription in response to carbohydrate 
availability is often controlled by the carbon catabolite protein CcpA (170).  Deletion of ccpA 
indirectly decreased transcription of atxA and also resulted in attenuation in a murine model 
for anthrax (32).  Finally, the pleiotropic DNA binding protein CodY which senses and 
responds to cell energy and nutrient status (71, 124, 135) was shown to affect AtxA 
stability.  AtxA protein levels decreased in a codY-null strain; however, atxA transcription, 
mRNA stability, and atxA translation were unaffected.  It has been suggested that the 
deletion of codY results in the synthesis of a protease that directly influences AtxA stability 
(168). 
 In addition to control of transcription initiation, atxA transcript stability is regulated.  
Transcription of atxA initiates from two start sites, P1 (36) located 99-nts upstream of the 
translational start and P2 (14) located 650-nts further upstream of P1.  Both P1 and P2 
appear to contain putative consensus sequences for the housekeeping sigma factor SigA 
and are therefore presumably controlled by SigA containing RNA polymerase (RNAP).  A 
positive retroregulation stem-loop structure starting 497-nts downstream from the atxA 
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translational stop codon has been shown to stabilize the mRNA (11).  The exact 
mechanism by which the long 3’ UTR regulates atxA expression is not completely 
understood; however, similar retroregulation systems are present in the control of B. 
thuringiensis cryotoxin genes (2, 176).   
 
1.7. Gaps in knowledge and significance of research 
 Several signals impact atxA expression; however, the cis-acting elements and trans-
acting factors that directly control transcription of atxA are largely unknown.  Multiple 
studies suggest that precise control of the timing and steady state level of atxA transcription 
are required for optimal expression of AtxA target genes in batch culture (18, 35, 68, 166).  
The timing and transcript level of atxA is impacted by growth phase, redox potential, 
temperature, and carbohydrate availability (32, 35, 131, 175).  Little is known regarding the 
direct mechanisms by which redox potential, temperature, or carbohydrate availability affect 
atxA transcription.  However, the B. anthracis growth phase/transition state regulator AbrB 
was shown to directly repress atxA transcription (131).  The AbrB binding site in the atxA 
promoter region overlaps the housekeeping sigma factor, SigA, putative -35 consensus 
sequence (151).  This suggests that AbrB represses atxA transcription by competing with 
SigA containing RNA polymerase for binding to the atxA promoter region.  Additional 
investigation of the cis-acting elements required for atxA transcription could impact our 
understanding of the molecular mechanisms controlling atxA.  The results of such 
investigations could also reveal additional trans-acting factor binding sites, other than the 
AbrB-binding site, required for atxA transcription.   
 In addition to affecting atxA transcription, AbrB regulates development of B. 
anthracis from the vegetative cell state to a dormant spore.  The spore constitutes the 
infectious form of B. anthracis; therefore, factors that affect B. anthracis sporulation may 
also impact virulence and pathogenesis.  The developmental regulators Spo0A, AbrB, and 
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SigH have been well-characterized in B. subtilis and were shown to possess similar 
functions in B. anthracis (see section 1.2).  Spo0A, AbrB and SigH are key components in 
the sporulation phosphorelay.  Deletion of spo0A or sigH abrogates sporulation in B. 
anthracis (68, 177).  In addition to their role in Bacillus species development, Spo0A, AbrB, 
and SigH also control atxA transcription.  AbrB binds to specific sequences in the atxA 
promoter region to repress transcription of atxA.  Spo0A positively affects atxA via control of 
abrB expression.  SigH control of atxA occurs via its positive effect on spo0A, and in one 
strain, sigH positively regulates atxA transcription in a spo0A- and abrB-independent 
manner (68, 151).  An atxA-null strain is avirulent in a murine model of anthrax disease 
demonstrating the necessity of atxA expression for virulence (36).  Experiments directed 
toward assessing the impact developmental regulators have on AtxA expression and 
virulence could provide a better understanding of the role the established regulatory 
network (Spo0A/AbrB/SigH) has on B. anthracis pathogenesis. 
 Other factors impacting B. anthracis sporulation are plasmid-encoded and positively 
influenced by AtxA.  Deletion of atxA in a Sterne-like strain (pXO1+, pXO2-) resulted in 
more efficient sporulation than parent when grown in a rich medium (75).  Expression of a 
B. thuringiensis plcR gene in a B. anthracis strain containing atxA resulted in a significant 
decrease in sporulation, a phenotype that was rescued by deletion of atxA.  B. anthracis 
contains a species-specific mutation within the plcR gene resulting in a truncated, non-
functional protein.  It has been proposed that coexpression of the AtxA- and PlcR-regulons 
in B. anthracis is not compatible; therefore, a mutation within the B. anthracis plcR occurred 
as a result of selective evolution (102).  Overexpression of the highly atxA-controlled gene 
pXO2-61 led to a marked decrease in B. anthracis sporulation resulting from a potential 
titration of signal from the sporulation sensor histidine kinase BA2291 (174).  These results 
suggest that AtxA not only controls B. anthracis virulence gene expression, but also 
regulates spore development.  Investigations into what role, if any, AtxA has on spore 
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development could provide evidence for a link between B. anthracis sporulation and toxin 
production.  Finally, by determining the molecular mechanisms controlling atxA expression, 
it can be determined what physiological relevance altered atxA expression has on B. 
anthracis disease progression. 
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2.1. Growth conditions   
 B. anthracis was grown in Luria-Bertani (LB) (6) medium for electroporations and 
DNA extractions. Cell lysates and culture supernatants for Western blot analysis were 
obtained from cells cultured in toxin-inducing (Casamino acids [CA] medium (161) buffered 
with 100 mM HEPES [pH 8.0] and 0.8% [wt/vol] sodium bicarbonate at an atmosphere of 
5% CO2) and/or sporulation (Phage assay [PA] medium (159) in atmospheric air) 
conditions.  Samples obtained for β-galactosidase assays were cultured in toxin-inducing 
conditions.  Briefly, an overnight culture of B. anthracis grown in LB medium supplemented 
with appropriate antibiotics and incubated with agitation at 30°C was used to inoculate 
CACO3 (toxin-inducing) or PA (sporulation) medium comprising 10% of the volume of an 
Erylenmeyer flask. Cultures were incubated at 37°C with agitation for sporulation conditions 
and 37°C with agitation and an atmosphere of 5% CO2 for toxin-inducing conditions. 
Antibiotics were added to media when necessary: spectinomycin (100µg/ml), erythromycin 
(300µg/ml for E. coli; 5µg/ml for B. anthracis), carbenicillin (100µg/ml).  All chemicals were 
purchased from Fisher unless otherwise stated. 
 
2.2. Strain construction  
 Strains and plasmids are shown in Table 2-1. B. anthracis strains were derived from 
the Sterne-like strains (pXO1+, pXO2-) ANR-1 (Ames non-reverting) and UM44, and the 
genetically complete Ames strain (pXO1+, pXO2+). E. coli TG1 and GM2163 strains were 
used for cloning purposes.  
Isogenic ∆atxA, ∆sigH, and ∆spo0A mutants were created in the ANR-1 strain 
(UT374, UT399, and UT400, respectively) and in the Ames background (UTA22, UTA16, 
and UTA28, respectively), using the markerless temperature-sensitive integration system 
described previously (120).  Oligonucleotide primers are shown in Table 2-2.  DNA 
sequences upstream of the atxA gene (-1009 to +99 relative to the P1 transcription start 
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site) were amplified using primers JR170 and JR171, and regions downstream of the atxA 
translational stop (+1528 to +2517) were amplified using primers JR172 and JR173. 
Regions surrounding sigH were amplified using primers JR119 and JR120 which amplified 
sequences from -1026 to -1 (relative to the sigH translational start site), and primers JR121 
and JR122 which amplified sequences from +658 to +1664. DNA sequences surrounding 
spo0A were amplified using primers JD191 and JD205 to amplify sequences from -1053 to 
+3 (relative to the spo0A translational start site) and primers JD206 and JD194 to amplify 
sequences from +793 to +1887. Splicing by overlap extension PCR (PCR-SOE) (79) was 
used to fuse the upstream and downstream fragments of each respective gene. The PCR-
SOE product was cloned into the temperature-sensitive integration vector pHY304.  
According to established protocols, strains were cultured until the desired mutation was 
discovered (120). 
Similar methods were used to create the isogenic atxA-up mutants in the ANR-1 
and Ames backgrounds, UT398 and UTA26, respectively.  Briefly, sequences surrounding 
the atxA ORF (-866 to +1527, relative to the P1 transcription start site) were amplified using 
primers TH134 and TH49 and cloned into pGEM-T easy (Promega, Madison, WI). 
Quickchange PCR (146) methods were used in combination with primers JD195 and JD196 
to mutate sequences from +14 to +22 relative to the atxA P1 transcription start. The 
mutated sequence was cloned into pHY304.  atxA was deleted from UTA26 to create strain 
UTA31 using DNA obtained from UTA26 for amplification purposes and the same methods 
described to create the single ∆atxA mutant.  Double deletion mutants containing ∆atxA, 
∆sigH, ∆spo0A, and atxA-up were created using the methods described above. 
 Creation of the ANR-1 ∆abrB (UT384), Ames ∆abrB (UTA27), Ames ∆pX02-61 
(UTA9), and any double mutants containing deletion of these genes utilized an Ω-spec 
cassette and methods described previously (131). Deletion of abrB from the ANR-1 strain 
background was performed using pUTE416 and methods described previously (131). To 
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delete abrB from the Ames strain background, regions surrounding abrB were amplified 
using primers JD176 and JD177 to amplify sequences from -839 to +3 (relative to the abrB 
translational start site) and primers JD178 and JD179 to amplify regions from +283 to 
+1123. 870-nts upstream (-838 to +13 relative to the translational start site) and 859-nts 
downstream (+441 to +1299) of the pX02-61 ORF were amplified using primer pairs 
KT3/KT4 and KT1/KT2, respectively. PCR products for the abrB mutation were cloned into 
pUTE583 while the pXO2-61 ORF deletion was cloned into pUTE568. The upstream and 
downstream fragments of the deletion construct flanked an Ω-spec cassette. pX02-61 was 
initially deleted from the Pasteur-like strain 9131(pX02) to create UT287 and further 
transduced into Ames using the CP51 phage (160). 
 B. anthracis strains harboring atxA promoter – lacZ (PatxA-lacZ) fusion vectors were 
constructed to monitor atxA promoter activity over time using β-galactosidase assays.  The 
atxA promoter region was amplified to generate several 5’ and 3’ truncated fragments which 
were subsequently cloned upstream of a promoterless lacZ gene on pHT304-18z (3) using 
HindIII and XbaI restriction enzyme sites.  Mutation of the putative SigA consensus 
sequence within the atxA promoter was performed using Quickchange PCR (146) and 
appropriate oligonucleotide primers (Table 2-2).    
 
2.3. DNA isolation and manipulation 
 Plasmid isolation from E. coli, transformations into E. coli, and recombinant 
techniques were performed using standard methods (6). Nonmethylated plasmid DNA for 
electroporation into B. anthracis (87, 98) was obtained from E. coli GM2163 cells. B. 
anthracis DNA extractions for verification purposes were performed using the UltraClean 
Microbial DNA Isolation Kit (Mo Bio Laboratories, Inc.). Restriction enzymes, T4 DNA 
lygase, and Taq polymerase were purchased from NEB.  
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2.4. Preparation of crude cellular extract  
 B. anthracis crude cellular extract was prepared as described previously (162) using 
some modifications. B. anthracis was cultured in 500-ml of CACO3 medium and an 
atmosphere of 5% CO2 to an OD600 of 0.6 – 0.8.  Cells were collected by passing cultures 
through a 0.2 µm polyethersulfone (PES) membrane filter (Corning Incorporated, Corning, 
NY). Cells were washed with 50 ml of TDE (10 mM Tris-HCl [pH 8.0], 1 mM EDTA [pH 8.0], 
100 mM KCl, 1 mM dithiothreitol, 10% ethylene glycol) followed by 30 ml of TEG (25 mM 
Tris-HCl [pH 8.0], 5 mM EGTA [pH 8.0]). Finally, cells were rinsed from the filter using 10 ml 
of TEG. Suspensions were centrifuged for 5 min at 2,260 x g at 4°C in a Rotanta 460 R 
Centrifuge. Supernates were discarded and cell pellets were stored at -80°C. The pellets 
were resuspended in a mixture of approximately 4 ml of TDE and 1.5 ml of TEG. To lyse 
the cells, each suspension was passed three times through a French press at 20,000 lb/in2. 
KCl was added to a final concentration of 100 mM and the lysates were centrifuged at 
58,820 x g for 1 h at 4°C using a Beckman TL-100 ultracentrifuge. To remove 
contaminating nucleic acids, 1/10th the volume of a 30% streptomycin sulfate solution was 
added in a dropwise manner to the lysate at 4°C and stirred for 30 min. The lysate was then 
centrifuged at 15,700 x g for 10 min at 4°C in an Eppendorf Centrifuge 5415 R. Proteins 
were precipitated with ammonium sulfate to 70% saturation at 4°C for 30 min and then 
centrifuged at 15,700 x g for 15 min at 4°C using an Eppendorf Centrifuge 5415 R. The 
precipitated protein pellet was resuspended in 1 ml of TDE and dialyzed in the same buffer. 
 
2.5. Electrophoretic mobility shift assays (EMSAs)  
 Primers used for probe construction are listed in Table 2-3.  Probes were 
radioactively labeled using direct PCR incorporation of α-32P dATP (Perkin Elmer, Boston, 
MA). Approximately 1 ng of radiolabeled probe was added to binding reactions consisting of 
500 ng synthetic DNA (PolydI-dC·PolydI-dC [Thermo Scientific, Milwaukee, WI]), 1-35 µg of 
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crude cellular extract, 10 µg bovine serum albumin [BSA], and TDE to a final volume of 10-
15 µl. When appropriate, 2.5- to 100-fold excess unlabeled competitor was added to each 
binding reaction.  The reactions were incubated for 15 min at room temperature (RT).  
DNA-protein complexes were resolved using electrophoresis on a 5% native 
polyacrylamide gel at 4°C. The gels were dried and visualized using a STORM 
phosphorImager (GE Healthcare, Piscataway, NJ). 
 
2.6. β-galactosidase assays   
 One-ml samples were obtained from cultures at early exponential (2h), transition 
(4h), and stationary (7h) phases of growth. β-galactosidase assays were performed as 
described by Miller et al. (105). Briefly, cell pellets were resuspended in Z-buffer (60mM 
Na2HPO4·7H2O, 40mM NaH2PO4·H2O, 10mM KCl, 1mM MgSO4·7H2O, 50mM β-
mercaptoethanol [added just prior to use]), transferred to tubes containing 400 µl of 0.1 mm 
Zirconia/Silica Beads (BioSpec Products, Bartlesville, OK) and bead beat for 1 min using a 
Mini BeadBeater (BioSpec Products) to lyse the cells. Debris was pelleted using 
centrifugation and the supernate was used to assay β-galactosidase activity.  Figures show 
data averaged from three independent cultures. 
 
2.7. Western blot analysis 
 Cell lysates and culture supernates were obtained from B. anthracis cultures grown 
in toxin-inducing and sporulation conditions during early exponential (2h), transition (4h), 
and stationary (7h) phases of growth. Four-milliliter samples were obtained per time point 
and centrifuged at 10,000 x g for 10 min. To assess lethal factor (LF), protective antigen 
(PA), and edema factor (EF) protein levels, 1 ml of corresponding supernatant was passed 
through a 0.2 µm filter (Thermo Scientific) and applied to a nitrocellulose membrane using a 
slot blot apparatus (Hoefer Scientific, San Francisco, CA). Protein loads were normalized to 
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OD600. Membranes were blocked overnight at 4°C in 1xTBS-T (20mM Tris base, 137mM 
NaCl, 0.1% tween 20, pH 7.6) containing 2.5% BSA. Primary antibody (α-LF, α-PA, or α-
EF) was resuspended in 1xTBS-T and allowed to react with the membrane for 1h at room 
temperature (RT). Membranes were washed with 1xTBS-T and further incubated with 
corresponding secondary antibody (goat α-rabbit-HRP [Bio-rad]) for 1h at RT. Membranes 
were washed as described above and developed using the SuperSignal West Dura 
Chemiluminescent Substrate (Thermo Scientific).  
 To assess AtxA protein levels, 4-ml cultures were centrifuged as described above. 
Cell pellets were washed twice with KTE-PIC (10 mM Tris-HCl pH 8, 100 mM KCl, 10% 
ethylene glycol, and EDTA-free Complete proteinase inhibitor [Roche]) and resuspended in 
KTE-PIC to a final volume of 450 µl. The cell resuspension was transferred to 1.5 ml screw-
cap tubes containing 400 µl of 0.1 mm Zirconia/Silica Beads. Samples were lysed 
mechanically for 2.5 min using a Mini BeadBeater, placed on ice for 5 min, and subjected to 
mechanical lyses for an additional 2.5 min.  After centrifugation, cell lysate was mixed with 
SDS sample buffer (5% glycerol, 100 mM DTT, 2% SDS, 40 mM Tris-Cl pH 6.8), boiled, 
and subjected to SDS-PAGE. Protein loads were determined based on OD600 values and 
normalized to RNA polymerase β (ANR-1-derivatives) or Ponceau S (0.1% [w/v] Ponceau S 
in 5% [v/v] acetic acid) stained membranes (Ames-derivatives). SDS-PAGE gels were 
equilibrated in 1 x CAPS Buffer (10 mM CAPS pH 11, 10% methanol) for 30 min prior to 
protein transfer. Proteins were transferred to a PVDF membrane at 4°C using a Hoefer 
transfer unit (Hoefer, Holliston, MA, USA) containing 1 x CAPS Buffer at 50 V for 2h.  
Membranes were blocked in 1xTBS-T containing 5% non-fat dry milk overnight at 4°C. 
Primary antibodies (α-AtxA [(70)] and α-RNA polymerase β [Santa Cruz Biotechnology, 
Santa Cruz, CA, USA]) were resuspended in 1xTBS-T and allowed to react with the 
membrane for 1h at RT.  The membranes were washed in 1xTBS-T and further incubated 
with corresponding secondary antibody (goat α-rabbit-HRP for AtxA Westerns, or goat α-
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mouse-HRP for RNA polymerase β Westerns) for 1h at RT. Blots were washed in 1xTBS-T 
and further developed using the SuperSignal West Dura Chemiluminescent Substrate. For 
re-probing, membranes were stripped using the Restore Western Blot Stripping Buffer 
(Thermo Fisher) for 30 min at 37°C.  
 
2.8. Heat-resistant CFU determination  
 Growth curves were performed using toxin-inducing and sporulation conditions. 
One-milliliter samples were obtained to determine the percentage of heat-resistant colony 
forming units (CFU) during transition (4h) and stationary (7h and 10h) phases of growth.  
Using LB, the B. anthracis cultures were serially diluted and 100 µl of the final dilution 
suspension was plated on LB agar using spread plating methods. The remaining dilution 
suspension was heat-shocked at 65°C for 45 min and plated as described above. All plates 
were incubated overnight at 37°C to determine numbers of heat-sensitive and heat-
resistant CFU. The percentage of heat-resistant CFU was calculated by dividing the 
number of heat-resistant CFU by the number of heat-sensitive CFU. 
 Samples used to determine total heat-resistant CFU/ml were obtained from cells 
cultured in sporulation conditions for 24 hours.  Using H2O, the B. anthracis cultures were 
serially diluted, heat-shocked at 65°C for 45 min, and 100 µl of the final dilution was plated 
on LB agar using spread plating methods.  All plates were incubated overnight at 37°C to 
determine the number of total heat-resistant CFU/ml.    
 
2.9. Preparation of B. anthracis vegetative cells for intravenous (i.v.) infection  
 B. anthracis spores (~107) were incubated in 1 ml of brain-heart infusion (BHI) 
medium for 10 min at 37°C. The entire spore outgrowth suspension was transferred to 25 
ml of CACO3 and incubated in 5% CO2 to an OD600 of approximately 0.6.  At this OD600, all 
cultures contained approximately 107 CFU/ml devoid of refractile spores as observed using 
 31 
phase contrast microscopy. Cultures were centrifuged at 5,708 x g for 10 min in a Sorval 
RC-5B Superspeed Centrifuge, the medium was removed, and the cells were washed with 
25 ml of 1 x Dulbecco’s phosphate-buffered saline (DPBS) without calcium or magnesium 
(Mediatech Inc., Manassas, VA). Cells were washed a total of two times and then 
resuspended in 25 ml of 1 x DPBS.  Prior to infection, an aliquot of the resuspension was 
diluted and plated on LB to determine the final CFU/ml inoculation dose. 
 
2.10. Mouse infections 
 All mouse protocols were approved by The University of Texas Health Science 
Center Institutional Animal Care and Use Committee and performed using accepted 
veterinary standards. Female 6- to 8-week-old A/J mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME) and maintained in a pathogen-free vivarium at The University 
of Texas Health Science Center. Food and water were supplied to the mice ad libitum. The 
mice were housed 3 per cage and were allowed to acclimate to their surroundings for 7 
days prior to being used in the experiments. Mice were infected intravenously using a 30-
gauge needle.  The tail vein was injected with 50 µl containing approximately 102 or 103 
heat sensitive CFU.   
 
2.11. Microscopy  
 B. anthracis cells were visualized using a Nikon Eclipse TE2000-U microscope and 
images were captured using MetaMorph version 6.2r6 (Universal Imaging Corporation). 
Phase contrast microscopy was used to visualize sporulating cells. India ink (Becton 
Dickinson Microbiology Systems, Sparks, MD) exclusion methods and DIC imaging were 
used to visualize capsule. 
 
2.12. RNA purification 
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 Four-milliliter samples were obtained from B. anthracis cultures during the transition 
(4h) phase of growth. Samples were centrifuged at 10,000 x g for 10 min at 4°C, the 
supernatant was decanted, and 500 µl of culture medium (CACO3 or PA) was added to 
each pellet.  Cell pellets were stored at -80°C. RNA was extracted using a hot acid-phenol 
method. An equal volume, 500 µl, of 65°C saturated acid phenol (pH 4.3 [Fisher]) was 
added to each sample and transferred to screw-cap tubes containing 400 µl of 0.1 mm 
Zirconia/Silica Beads. The samples were homogenized for 1 min using a Mini BeadBeater, 
incubated at 65°C for 5 min, and bead-beat for an additional 1 min. Homogenized samples 
were centrifuged at 16,000 x g for 3 min at 4°C. Following centrifugation, the aqueous 
phase was transferred to a new 2 ml Eppendorf tube and 500 µl of 65°C saturated acid 
phenol was added to remove any remaining organic material. Samples containing saturated 
acid phenol were vortexed, incubated at room temperature (RT) for 5 min, and centrifuged 
at 16,000 x g for 3 min at 4°C. Following centrifugation, 0.3 volumes of chloroform was 
added to the aqueous phase and incubated at RT for 10 min with agitation. The mixture 
was centrifuged for 15 min at 16,000 x g at 4°C and the aqueous phase was transferred to 
a sterile tube. To precipitate the RNA, ½ starting volume of DEPC-treated H2O and 1 
volume isopropanol was added to the aqueous phase and incubated at RT for 10 min. RNA 
was pelleted at 4°C for 15 min at 16,000 x g. The supernatant was removed and RNA 
pellets were washed with 75% ice-cold EtOH, dried in an Eppendorf Vacufuge (Brinkmann 
Instruments, Inc., Westbury, NY), and resuspended in DEPC-treated H2O. RNA 
concentrations were quantified using a NanoDrop Spectrophotometer ND-1000 (Thermo 
Scientific).    
 
2.13. Real-time quantitative PCR (RT-qPCR)  
 Purified RNA samples (2.5 – 5 µg) were DNase treated using 5U of RQ1 DNase 
enzyme (Promega) for 30 min at 37°C. DNase reactions were stopped using 0.1 volume or 
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5 µl (whichever was greater) RQ1 stop buffer (Promega) and incubated at room 
temperature for 2 min.  DNase-treated RNA was precipitated with 1/10th volume of 3 M Na-
acetate pH 5.2 (Ambion, Grand Island, NY) and 2 volumes of ice-cold 100% EtOH for a 
minimum of 30 min on ice. The mixture was centrifuged at 16,000 x g for 30 min at 4°C. 
RNA pellets were washed with 1 ml of ice-cold 75% EtOH, dried in an Eppendorf Vacufuge, 
and resuspended in DEPC-treated water. RNA concentrations were quantified using a 
NanoDrop Spectrophotometer ND-1000.  RT-qPCR assay information is provided in Table 
2-4.  RT-qPCR assays were performed in the Quantitative Genomics Core Laboratory at 
The University of Texas Health Sciences Center in Houston, Texas. All real-time qPCR 
assays used in this publication were designed and validated by QGCL staff to ensure they 
pass the minimum requirements for efficiency, sensitivity and template specificity. 
 cDNA was synthesized in 5 µl (384-well plate) total volume by the addition of 
3 µl/well RT master mix consisting of: 400 nM assay-specific reverse primer, 
500 µM deoxynucleotides, Superscript II (or Affinityscript) buffer and 1 U/µl 
Superscript II (or Affinityscript) reverse transcriptase (Invitrogen, Carlsbad, 
CA), to a 384-well plate (Applied Biosystems, Foster City, CA) and followed 
by a 2 µl volume of sample (25-50 ng/µl). For 96-well plates, 6 µl RT master 
mix was added to each well followed by 4 µl of RNA sample (25 ng/µl). Each 
sample was assayed in triplicate plus a control without reverse transcriptase 
to access DNA contamination levels. Each plate also contained an assay-
specific sDNA (synthetic amplicon oligo) standard spanning a 5-log template 
concentration range and a no template PCR control. Both were added into 
RT master mix with reverse transcriptase. Each plate was covered with 
Biofilm A (Bio-Rad, Hercules, CA) and incubated in a PTC-100 or DYAD 
thermocycler (Bio-Rad, Hercules, CA) for 30 min at 50˚C followed by 72˚C for 
10 min. PCR master mix, 15 µ l/well, was added directly to the 5 µ l RT 
volume. Final concentrations for the PCR were 400 nM forward and reverse 
primers (IDT, Coralville, IA), 100 nM fluorogenic probe (Biosearch 
Technologies, Novato, CA), 5 mM MgCl2, and 200 µM deoxynucleotides, 
PCR buffer, 150 nM SuperROX dye (Biosearch Technologies, Novato, CA) 
and 0.25 U JumpStart Taq polymerase per reaction (Invitrogen, Carlsbad, 
CA), final concentrations. RT master mixes and all RNA samples and DNA 
oligo standards were pipetted by a Tecan Genesis RSP 100 robotic 
workstation (Tecan US, Research Triangle Park, NC); PCR master mixes 
were pipetted utilizing a Biomek 2000 robotic workstation (Beckman, 
Fullerton, CA). Each assembled plate was then covered with optically clear 
film (Applied Biosystems, Foster City, CA) and run in a 7900 real-time 
instrument using the following cycling conditions: 95˚C, 2 min; followed by 40 
cycles of 95˚C, 12 sec and 60˚C, 30 sec. The resulting data were analyzed 
using SDS 2.3 (7900) software (Applied Biosystems, Foster City, CA) with 
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FAM reporter and ROX as the reference dye. Synthetic, PAGE purified DNA 
oligos used as standards (sDNA) encompassed at least the entire 5’ – 3’ 
PCR amplicon for the assay (Sigma-Genosys, The Woodlands, TX). Each 
oligo standard was diluted in 100 ng/µ l E. coli tRNA-H2O (Roche Diagnostics, 
Indianapolis, IN) and spanned a 5-log range in 10-fold decrements starting at 
0.8 pg/reaction (24, 56, 72, 109). It has been shown for several assays that in 
vitro transcribed RNA amplicon standards (sRNA) and sDNA standards have 
the same PCR efficiency when the reactions are performed as described 
above with PCR amplicons of less than 100 bases in length (G.L. Shipley, 
personal communication). 
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Table 2-1. Strains and plasmids used in this study. 
 
Name Descriptiona Source or reference 
Strains   
UM44 Webridge strain, pXO1+, pXO2-, Ind- C. Thorne 
   UT291 UM44-derived ∆abrB/sigH mutant, Spo-, 
SpcR, KanR 
Hadjifrangiskou et al. 2007 
ANR-1 Ames strain, pXO1+, pXO2- Welkos et al. 2001 
   UT374 ANR-1-derived ∆atxA mutant This work 
   
UT374(pUTE926) 
UT374 containing the atxA complementation 
vector pUTE926 
This work 
   UT375 ANR-1-derived ∆lef mutant Hammerstrom et al. 2011 
   UT384 ANR-1-derived ∆abrB mutant This work 
   UT399 ANR-1-derived ∆sigH mutant This work 
   UT398 ANR-1-derived atxA-up mutant; mutated at 
positions +14 to +22 
This work 
   UT400 ANR-1-derived ∆spo0A mutant This work 
   UT401 ANR-1-derived ∆spo0A/abrB mutant This work 
   UT402 ANR-1-derived ∆spo0A/sigH mutant This work 
Ames pXO1+, pXO2+ Ravel et al. 2009 
   UTA9 Ames-derived ∆pXO2-61 mutant This work 
   UTA16 Ames-derived ∆sigH mutant This work 
   UTA22 Ames-derived ∆atxA mutant This work 
   UTA26 Ames-derived atxA-up mutant; mutated at 
positions +14 to +22 
This work 
   UTA27 Ames-derived ∆abrB mutant This work 
   UTA28 Ames-derived ∆spo0A mutant This work 
   UTA29 Ames-derived ∆spo0A/sigH mutant This work 
   UTA30 Ames-derived ∆spo0A/abrB mutant This work 
   UTA31 Ames-derived ∆pXO2-61/atxA-up mutant This work 
   UTA32 Ames-derived ∆atxA/atxA-up mutant This work 
 
Plasmids 
  
pHT304-18z Promoterless lacZ vector, AmpR in E.coli, 
ErmR in B. anthracis 
D. Lereclus 
pUTE839 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -770 
to +99 
This work 
pUTE843 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -72 to 
+99 
This work 
pUTE890 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -56 to 
+99 
This work 
pUTE891 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -36 to 
+99 
This work 
pUTE901 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -8 of the SigA 
consensus 
This work 
pUTE902 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -35 of the SigA 
consensus 
This work 
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pUTE904 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -11 of the SigA 
consensus 
This work 
pUTE905 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -9 of the SigA 
consensus 
This work 
pUTE906 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -34 of the SigA 
consensus 
This work 
pUTE907 pUTE843-derived atxA promoter - lacZ fusion 
vector; mutated at position -30 of the SigA 
consensus 
This work 
pUTE914 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -72 to 
+13 
This work 
pUTE915 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -72 to 
+61 
This work 
pUTE918 pHT304-18z-derived atxA promoter - lacZ 
fusion vector; contains sequences from -72 to 
+31 
This work 
pUTE926 
 
pUTE971 
atxA complementation vector; contains 
sequences from -72 to +1527  
pHT304-18z-derived atxA promoter – lacZ 
fusion vector; contains mutated sequences 
from +14 to +22 
This work 
 
This work 
   
anumeric values relative to atxA P1 transcriptional start 
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Table 2-2. Primers used in this study. 
 
Name Sequence (5' to 3')a Brief descriptionb 
 
JR170 
 
GGCCGCGGAGAGCCGCATTAAACT 
 
atxA markerless mutation (SacII) 
JR171 GGGCATGTCTATAATTGATTCTCCTTTCCTG atxA markerless mutation  
JR172 GAGAATCAATTATAGACATGCCCTTTAAATA
TTTGTTTAATGACAC 
atxA markerless mutation 
JR173 GGCTCGAGCGCTTGTCTCACAATCTCATC atxA markerless mutation (XhoI) 
JR119 GGGCTCGAGATGAAATTGAAGACCCGCAT sigH markerless mutation (XhoI) 
JR120 GTAGCTCTTGTTACTTGATCCCTCCGACCGC
TA 
sigH markerless mutation 
JR121 GTCGGAGGGATCAAGTAACAAGAGCTACAG
GTGTAAAAAATCACCTG 
sigH markerless mutation 
JR122 GGGCTCGAGTCTCATGAAGTTCAAAGTCGA
AATC 
sigH markerless mutation (XhoI) 
JD176 TCTAGACTCCTATTGGAAATTTAGAAGATAT
GAC 
abrB allelic exchange (XbaI) 
JD177 TATGGGATCCTAAGCTTCTCAATTATGAGAA
GC 
abrB allelic exchange (BamHI) 
JD178 CTTAGGATCCCATAATTCTTTTCCTCCTAAA
GAAATAG 
abrB allelic exchange (BamHI) 
JD179 GTCGACGATCTACTAGTTGCTTGAAGATTTT
TTC 
abrB allelic exchange (SalI) 
JD191 CCCTCTAGACACGGCTAATGCTGTCGGTC spo0A markerless mutation (XbaI) 
JD205 CTTTTCGACACTGAGAATAGAAGAAGTAAGA
GATTTAAG 
spo0A markerless mutation 
JD206 AGATAAGAGTCACAGCTTTTCCTCCCTTACC
G   
spo0A markerless mutation 
JD194 CCCGTCGACGGAAACAGGCGAACCGCTTA spo0A markerless mutation (SalI) 
KT1 GAATTCCATCACCGTTAGTGAATCCT pXO2-61 allelic exchange (EcoRI) 
KT2 GGATCCTCGGTAAAGACAGAGAAAGC pXO2-61 allelic exchange (BamHI) 
KT3 GGATCCTATCGACAAAGAAGGCATTT pXO2-61 allelic exchange (BamHI) 
KT4 GAGCTCAGTATGCTTTGCATTTTGGT pXO2-61 allelic exchange (SacI) 
YC9-1 AAGCTTAAAAAACTAATAACCCCCCT atxA locus -770 (HindIII) 
JD50  AAGCTTAGAAACAAAAAACCAATTTTTCC atxA locus -72 (HindIII) 
JD89 AAGCTTTTTCCCTTAAAAAAATCATTCCC atxA locus -56 (HindIII) 
JD90 AAGCTTCCCAAAATATGTGTTTTGAAATATAA atxA locus -36 (HindIII) 
JD111 AAGCTTTATAATAGCATTTGTCAGGTCATCT
G 
atxA locus -13 (HindIII) 
JD228 TATAATAGCATTTGTCAGGTCATCTG atxA locus -13   
JD37 TCTAGAGTCTATAATTGATTCTCCTTT  atxA locus +99 (XbaI) 
JD107 CAGAATATTAGAATTAACGGACATTTAAC atxA locus +61 
JD112 TCTAGACAGAATATTAGAATTAACGGACATT
TAAC 
atxA locus +61 (XbaI) 
JD108 GTATTTTAACCATGTCATCAGATGA atxA locus +31  
JD113 TCTAGAGTATTTTAACCATGTCATCAGATGA atxA locus +31 (XbaI) 
JD109 CAGATGACCTGACAAATGCTATTATA atxA locus +14 
JD114 TCTAGACAGATGACCTGACAAATGCTATTAT
A 
atxA locus +14 (XbaI) 
JD110 AAGCTTTCAGGTCATCTGATGACATGGTTAA atxA locus +2 (HindIII) 
JD229 TTAACGGTATTTTAACCATGTCATC atxA locus +36 
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JD95 CCCAAAATATGTGTTTTGAAATGTAATAGCA
TTTGTCAGGTCATC 
atxA promoter SigA -11 SDM 
JD96 GATGACCTGACAAATGCTATTACATTTCAAA
ACACATATTTTGGG 
atxA promoter SigA -11 SDM 
JD97 CAAAATATGTGTTTTGAAATATTATAGCATTT
GTCAGGTCATCTG 
atxA promoter SigA -9 SDM 
JD98 CAGATGACCTGACAAATGCTATAATATTTCA
AAACACATATTTTG 
atxA promoter SigA -9 SDM 
JD99 AAAATATGTGTTTTGAAATATATTAGCATTTG
TCAGGTCATCTGA 
atxA promoter SigA -8 SDM 
JD100 TCAGATGACCTGACAAATGCTAATATATTTC
AAAACACATATTTT 
atxA promoter SigA -8 SDM 
JD101 CCAATTTTTCCCTTAAAAAAATCAGTCCCAA
AATATGTGTTTTGAAATA 
atxA promoter SigA -35 SDM 
JD102 TATTTCAAAACACATATTTTGGGACTGATTTT
TTTAAGGGAAAAATTGG 
atxA promoter SigA -35 SDM 
JD103 CAATTTTTCCCTTAAAAAAATCATGCCCAAAA
TATGTGTTTTGAAATAT 
atxA promoter SigA -34 SDM 
JD104 ATATTTCAAAACACATATTTTGGGCATGATTT
TTTTAAGGGAAAAATTG 
atxA promoter SigA -34 SDM 
JD105 TTCCCTTAAAAAAATCATTCCCGAAATATGT
GTTTTGAAATATAA 
atxA promoter SigA -30 SDM 
JD106 TTATATTTCAAAACACATATTTCGGGAATGAT
TTTTTTAAGGGAA 
atxA promoter SigA -30 SDM 
JD195 CATTTGTCAGGTCATCTGCGTCACGTTTTAA
AATACCGTTAAATG 
atxA promoter SDM +14 to +22 
JD196 CATTTAACGGTATTTTAAAACGTGACGCAGA
TGACCTGACAAATG 
atxA promoter SDM +14 to +22 
TH49 GCGAAAGCTTATATTATCTTTTTGATTTCATG atxA-up markerless mutation 
(+1527, HindIII) 
TH134 GACAAAAATAAAATAGAATTGAATTCTTTTTA
ATATAATC 
atxA-up markerless mutation (-866, 
EcoRI) 
JD139 TCGAAGTAATTGCCCTAGTGAAG PspoVG probe 
JD124 
JD230 
JD231 
CTTGTGTTCACCACCCTTTTC 
AGTTTATTTTGTAATAGTGTCATCAGG 
ACTTGGAAACTAGGGCGAG 
 
PspoVG probe 
PcodY probe 
PcodY probe 
  
 
aunderline denotes restriction site 
bnumeric values relative to atxA P1 transcriptional start 
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Table 2-3. atxA promoter probes used in this study. 
Probe size 
(bp) 
Sequence 
(relative to atxA P1 transcription start site) Primers used 
171 -72 to +99 JD50, JD37 
133 -72 to +61 JD50, JD107 
103 -72 to +31 JD50, JD108 
85 -72 to +14 JD50, JD109 
97 -36 to +61 JD90, JD107 
74 -13 to +61 JD111, JD107 
60  +2 to +61 JD110, JD107 
49 -13 to +36 JD228, JD229 
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Table 2-4. RT-qPCR primers and probes used in this study. 
Name 
Sequence 
(and nucleotide in relation to start codon (and strand)) 
Accession 
number 
PCR 
efficiency 
(%) 
Length of 
product 
(bases) 
gyrB F ACTTGAAGGACTAGAAGCAG (54(+)) NC_007530 99 68 
gyrB R GTCCTTTTCCACTTGTAGATC (121(-)) NC_007531 99 68 
gyrB probe FAM-CGAAAACGCCCTGGTATGTATA-BHQ1 (76(+)) NC_007532 99 68 
atxA F ATTTTTAGCCCTTGCAC (774(+)) NC_003980 93 71 
atxA R AAGTTAATGTTTTATTGCTGTC (884(-)) NC_003981 93 71 
atxA probe FAM-CTTTTATCTCTTGGAAATTCTATTACCACA-BHQ1 
(795(+)) 
NC_003982 93 71 
pXO2-61 F GTGAATAAATTCAGCAATA (154(+)) AE17335 95 75 
pXO2-61 R GAGATAGAAATAACATCCA (228(-)) AE17336 95 75 
pXO2-61 probe FAM-TTTGCATCAATACGCTCTCTTG-BHQ1 (179(+)) AE17337 95 75 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 41 
 
 
 
 
 
 
 
 
 
Chapter III 
An unidentified trans-acting repressor protein(s) directly regulates 
expression of atxA  
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3.1. Introduction 
 Regulation of gene expression at the level of transcription is often associated with 
trans-acting proteins and cis-acting promoter sequences that work in concert to affect the 
function of RNA polymerase (RNAP). In response to environmental cues, regulatory 
proteins can interact directly with RNAP to alter its activity or interact with specific 
sequences or structures in the promoter region to impact RNAP binding or processivity. 
Certain genes are subject to complex control in which multiple trans-acting factors and 
sequences in the promoter region function coordinately or independently to affect 
transcription (reviewed in (94)). The major virulence gene regulator of Bacillus anthracis, 
AtxA, positively affects transcription of the anthrax toxin and capsule biosynthetic genes 
(36, 40, 50, 67, 87, 101, 136, 165, 166). AtxA has motifs associated with DNA-binding, 
PTS-dependent phosphorylation, and multimerization (70, 85, 164, 166), but the precise 
molecular mechanism by which AtxA impacts transcription is not clear. Nevertheless, 
steady state levels of AtxA are critical for optimal transcription of the anthrax toxin and 
capsule genes (18, 35, 40, 68, 166).  
Multiple signals have been shown to impact atxA transcript and protein levels.  
These signals include temperature, carbohydrate availability, redox potential, metabolic 
state, and growth phase.  In agreement with the significance of AtxA in pathogenesis, atxA 
transcript levels are 5- to 6-fold greater in cultures grown at 37°C compared to cultures 
incubated at 30°C (35).  In the presence of glucose, the catabolite control protein CcpA 
stimulates transcription of atxA indirectly by an unknown mechanism (32).  The redox state 
of the cell also appears to control atxA transcription.  Wilson et al. (175) showed early and 
increased expression of atxA when small c-type cytochromes were deleted.  However, the 
enhanced atxA expression was only apparent when cells were cultured in medium not 
conducive for toxin production, so relevance for the small c-type cytochromes in virulence 
may be minimal.  Another trans-acting factor, CodY, post-translationally controls AtxA 
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protein levels.  A codY-null mutant produces less AtxA than parent due to an unknown 
mechanism (168).   
 Only one trans-acting factor has been reported to bind directly to the atxA promoter 
region. The transition state regulator AbrB represses atxA transcription by binding to a 43-
bp region located 25 to 67 bp upstream of the P1 transcription start site (151). atxA 
expression is increased in an abrB-null mutant (68, 131).  AbrB has been well studied in the 
archetype Bacillus species B. subtilis as a transcriptional regulator associated with cell 
development.  The AbrB regulon includes several post-exponential phase genes associated 
with metabolic and physiological processes.  Transition state regulators such as AbrB 
function to prevent the inappropriate expression of genes whose products have growth 
phase–specific functions (121, 150).  AbrB is part of a feedback loop of regulators including 
the master response regulator Spo0A and the alternative sigma factor SigH.  In B. subtilis, 
SigH positively affects spo0A, phosphorylated Spo0A represses abrB, and AbrB represses 
sigH (54, 66, 122, 147, 148).  B. anthracis homologues of these proteins appear to perform 
similar roles, but in addition, they impact transcription of atxA.  AbrB directly binds the atxA 
promoter region repressing transcription, and Spo0A positively controls atxA expression by 
repressing abrB.  The B. anthracis spo0A promoter has a SigH recognition sequence 
comparable to that of the B. subtilis gene (68).  SigH control of atxA occurs via its positive 
affect on spo0A, and in one strain, sigH positively regulates atxA expression in a spo0A- 
and abrB-independent manner (14, 68, 131, 151). 
 Transcription of atxA initiates from two start sites, P1 (36) located 99-nts upstream 
of the translational start site, and P2 (14) located an additional 650-nts upstream of P1.  A 
modest decrease in atxA expression was observed upon deletion of P2 demonstrating P1 is 
the dominant transcription start site (14).  There is a putative consensus sequence for the 
housekeeping sigma factor SigA, but not SigH, upstream of each transcription start site.  
However, direct transcription of atxA by SigA-RNAP has not been established.  In addition 
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to control of transcription initiation, atxA mRNA stability is regulated.  An extended 3’ UTR 
contains a positive retroregulation stem-loop structure thought to protect atxA mRNA from 
exonucleolytic degradation (11, 176).   
 In this study, I sought to delineate cis-acting elements associated with regulation of 
atxA transcription and to test for the presence of additional trans-acting factors controlling 
transcription of atxA.  Here I show that a region with similarity to the consensus sequence 
for recognition by SigA, and an UP element 5’ of P1, the major transcription start site, are 
required for atxA transcription from P1. I also provide evidence for binding of a trans-acting 
repressor(s) other than AbrB to a palindromic sequence located downstream of the atxA P1 
transcription start site.  Elevated atxA transcription in a mutant altered for the repressor-
binding site resulted in increased AtxA and anthrax toxin production. Nevertheless, 
virulence was unaffected by overexpression of AtxA. 
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3.2. Results 
 
3.2.1. The SigA consensus sequence is required for transcription from P1. 
 Dai et al. (36) reported previously the presence of a putative consensus sequence 
for the housekeeping sigma factor SigA upstream of the atxA P1 transcription start site from 
sequences -36 to -8, relative to P1.  This region of the atxA promoter differs from the 
established B. subtilis SigA consensus by two nucleotides within the putative -35 region 
(TTccCA).  To determine if the putative SigA consensus is required for atxA transcription, I 
mutated single nucleotides within the -35 and -10 consensus regions and monitored atxA 
promoter activity using β-galactosidase assays.  DNA sequences (171-bp) containing 
mutated and non-mutated atxA promoter regions (Fig. 3-1) were transcriptionally fused to a 
promoterless lacZ gene and introduced into B. anthracis.  During culture in conditions 
conducive for toxin gene expression (CACO3 + 5% CO2), the parent strain harboring the 
native atxA promoter-lacZ fusion exhibited a maximum β-galactosidase activity of 60 Miller 
Units (MU) at the transition to stationary phase (Fig. 3-2), consistent with previous reports 
of atxA expression (68, 131).  Mutation of any single nucleotide within either the predicted 
SigA -35 or -10 region resulted in little to no β-galactosidase activity (Fig. 3-2).  These 
results indicate that the putative SigA consensus located upstream of P1 is required for 
atxA promoter activity and suggest that SigA-RNAP transcribes atxA from the P1 initiation 
site.  
 
3.2.2. A trans-acting protein(s) other than AbrB binds specifically to the atxA 
promoter region.  
 The only trans-acting factor that has been shown to directly bind to DNA within the 
atxA promoter region is the transition state regulator AbrB (131, 151). To determine if trans-
acting factors other than AbrB bind to atxA promoter DNA, I performed electrophoretic  
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Figure 3-1. Schematic representation of the atxA promoter region.  The DNA 
fragments used for electrophoretic mobility shift assays (denoted by x-bp) and 5’ or 3’ 
deletion fragments cloned into a promoterless lacZ construct (denoted by a pUTE#) are 
depicted below the atxA promoter.  The putative 9-bp palindrome sequence is located 
between positions +3 to +21 (grey bars).    
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Figure 3-2. Evidence for SigA-dependent atxA transcription.  B. anthracis mutants 
containing transcriptional PatxA-lacZ fusions were cultured in CACO3 + 5% CO2.  β-
galactosidase activity was assessed at early exponential (2h), transition (4h), and stationary 
(7h) phases of growth.  Specific mutations within the putative SigA -35 and -10 consensus 
sequences are denoted by lowercase, bold lettering.  A representative growth curve is 
depicted by the hashed line with diamond symbols.  These data were averaged from 
three independent cultures. 
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mobility shift assays (EMSAs) using B. anthracis crude cellular extracts from cultures grown 
in toxin-inducing conditions and a radiolabeled atxA promoter probe.  Soluble cell extract 
was obtained from an abrB/sigH-null strain to eliminate transcription factors previously 
reported to influence atxA transcription (68, 131, 151).  A 171-bp atxA promoter (PatxA) 
region containing the AbrB binding site, SigA consensus, and sequences from P1 to the 
translational start of atxA (+1 to +99) was used as the radiolabeled atxA probe (Fig. 3-1).  
Addition of 10 µg cellular extract resulted in a DNA-shift of the 171-bp PatxA probe.  To 
show specificity of the shift, increasing concentrations of unlabeled PatxA were added to 
the binding reactions as cold competitor.  The addition of unlabeled PatxA competitor 
resulted in a diminished DNA-shift and an increased abundance of free probe (Fig. 3-3A).  
The spoVG promoter (PspoVG) was used as a nonspecific unlabeled competitor.  spoVG is 
controlled by both SigH-RNAP and AbrB (52, 126), two transcription factors also shown to 
control atxA transcription.  Addition of increasing concentrations of unlabeled PspoVG 
competitor did not result in a diminished DNA-shift (Fig. 3-3A).  These results indicate that a 
trans-acting factor(s) other than AbrB and SigH binds specifically to the atxA promoter 
region and not the spoVG promoter.   
 I considered that the factor responsible for the DNA-shift might be SigA-RNAP 
because the 171-bp atxA promoter probe contained the SigA consensus required for atxA 
transcription.  To determine if SigA-RNAP was the trans-acting factor(s) that led to a 
specific DNA mobility shift, I used an unlabeled competitor DNA that contained a mutation 
within the SigA -35 consensus (gTCCCA).  This mutation abolished atxA promoter activity 
in β-galactosidase assays (Fig. 3-2).  Similar to competition with the unlabeled non-mutated 
PatxA DNA, excess PatxA DNA harboring the mutated SigA -35 consensus sequence 
resulted in a diminished DNA-shift (Fig. 3-3B).  These results suggest that the observed 
DNA mobility shift is not attributed to SigA-RNAP binding the atxA promoter region. 
 Treatment of B. anthracis cellular extract with proteinase K resulted in protein 
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Figure 3-3. A trans-acting factor(s) binds specifically to the atxA promoter region.  B. 
anthracis sigH/abrB-null soluble cellular extract mixed with radiolabeled 171-bp PatxA.  
Soluble cellular extract was obtained from cells cultured in CACO3 + 5% CO2.  (A) EMSAs 
using increasing concentrations of PatxA (2.5- to 80-fold excess) and PspoVG (10- to 50-
fold excess) unlabeled competitors.  (B) EMSAs using 50-fold more specific and non-
specific unlabeled competitors than radiolabeled PatxA.  Unlabeled competitors include 
171-bp PatxA (white star), 171-bp PatxA with mutated SigA -35 sequence (gTCCCA; dotted 
star), and non-specific 187-bp PspoVG (black star).  These data are representative of three 
separate experiments.  
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degradation and a diminished DNA-shift (Fig. 3-4), indicating that the trans-acting factor(s) 
is a protein(s). In addition, cellular extract obtained from a plasmid-cured B. anthracis strain 
added to the PatxA probe resulted in a DNA-shift indicating the trans-acting protein(s) is 
encoded by the chromosome (data not shown).  Taken together, these results indicate that 
a trans-acting protein(s) other than AbrB, SigH, or SigA-RNAP specifically binds the atxA 
promoter region.  
 
3.2.3. Additional cis-acting regulatory elements located within the atxA promoter 
region. 
 In order to identify a putative binding site for the PatxA specific trans-acting 
protein(s) within the atxA promoter region and reveal any additional cis-acting elements 
controlling atxA, I performed 5’ and 3’ deletion analysis of the atxA promoter region.  
Truncated atxA promoter regions transcriptionally fused to the promoterless lacZ gene were 
introduced into B. anthracis and β-galactosidase assays were used to monitor atxA 
promoter activity (Fig. 3-1 and Fig. 3-5).  Comparison of strains carrying pUTE839 and 
pUTE843 showed that deletion of P2 resulted in a 1.7-fold decrease in atxA promoter 
activity (Fig. 3-5A). Similar results showing a modest change in atxA promoter activity upon 
P2 deletion were reported by Bongiorni et al. (14).  Activity of a clone harboring only the P1 
start site (pUTE843) decreased 3.2-fold when sequences from -72 to -54 relative to the P1 
transcription start site (+1) were deleted (pUTE890).  An additional 16.9-fold decrease in 
atxA promoter activity was observed when sequences from -72 to -36 were deleted 
(pUTE891).  These results indicate the presence of a positive cis-acting element located 
within the sequences from -72 to -35.  This region is A+T-rich and sequences from -65 to -
44 resemble an UP-element recognized by the α-subunits of RNAP (62).  The data suggest 
that SigA-RNAP requires all or some of the sequences from -72 to -35 for maximal atxA 
transcription.    
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Figure 3-4. A trans-acting protein(s) binds specifically to the atxA promoter region.  
Proteinase K treated B. anthracis soluble cellular extract incubated with radiolabeld 171-bp 
PatxA.  Soluble cellular extract was obtained from cells cultured in CACO3 + 5% CO2.  
Cellular extract was treated with 0, 10, 100, and 1000 µg/ml of proteinase K for 30 min at 
room temperature.  (A) EMSAs using soluble cellular extract that was incubated with 
increasing concentrations of proteinase K.  Unlabeled competitors include 171-bp PatxA 
(white star) and non-specific 187-bp PspoVG (black star).  (B) Coomassie stained SDS-
PAGE of proteinase K treated soluble cellular extract.    These data are representative of 
three separate experiments. 
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Figure 3-5.  5’ and 3’ atxA promoter deletion analysis. (A) 5’ PatxA deletion constructs 
and (B) 3’ PatxA deletion constructs transcriptionally fused to a promoterless lacZ gene, 
and corresponding β-galactosidase assays.  B. anthracis ANR-1 harboring the PatxA-lacZ 
constructs were cultured in toxin-inducing conditions and samples were obtained during 
early exponential (2h), transition (4h) and stationary (7h) phases of growth.  Symbols: 
pUTE839 / 904-bp PatxA (triangles – purple), pUTE843 / 171-bp PatxA (squares – green), 
pUTE890/153-bp PatxA (star - pink), pUTE891 / 135-bp PatxA (X – teal), pUTE915 / 133-
bp PatxA (X – orange), pUTE918 / 103-bp PatxA (star – blue) pUTE914 / 85-bp PatxA 
(triangle – red), empty vector (diamond – yellow).  These data were averaged from three 
independent cultures. 
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 The 3’ deletion analysis showed a 14.9-fold increase in atxA promoter activity when 
sequences from +14 to +31 (pUTE914), relative to the P1 transcription start site (+1), were 
deleted (Fig. 3-5B).  Deletion of sequences from +31 to +99 (pUTE915 and pUTE918) 
resulted in no measurable difference in atxA promoter activity compared to the full-length 
atxA promoter control (pUTE843).  These results suggest that a repressor protein(s) binds 
to the atxA promoter region and that sequences downstream of the P1 initiation site (+1) 
are required for binding.  Together, the 5’ and 3’ atxA promoter deletion analyses indicate 
that sequences upstream and downstream of the P1 transcription initiation site (+1) are 
important for regulation of atxA promoter activity.  
 
3.2.4. A putative repressor protein(s) binding site is located near the P1 transcription 
start site. 
 To define the cis-acting region required for repressor protein(s) binding, I performed 
EMSAs using truncated atxA promoter regions as radiolabeled probes and cellular extract 
from B. anthracis ANR-1.  Similar DNA-shifts were observed using cellular extracts 
prepared from an abrB/sigH-null strain (data not shown).  As seen previously, a DNA-shift 
was observed when cellular extract was added to the 171-bp PatxA probe containing the 
AbrB binding site, SigA consensus, and sequences from P1 to the translational start of atxA 
(+1 to +99).  The DNA-shift was specific for the atxA and not spoVG promoter since excess 
unlabeled PatxA but not unlabeled PspoVG resulted in a diminished DNA-shift (Fig. 3-6A).  
Specific DNA-shifts were also observed when the atxA promoter probe was truncated from 
the 3’ end to produce 133- and 103-bp probes indicating that atxA promoter sequences 
from +32 to +99 are not required for repressor protein binding (Fig. 3-6A).  These results 
are in agreement with the comparable β-galactosidase activity of transcriptional fusions 
carrying the 171-, 133-, and 103-bp atxA promoter regions (Fig. 3-5B).  3’ deletion of an 
additional 18-bp containing sequences from +14 to +31 (85-bp PatxA probe) resulted in a 
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Figure 3-6. Defining the cis-acting region required for trans-acting protein(s) binding.  
B. anthracis cellular extract obtained from cells cultured in CACO3 + 5% CO2 was incubated 
with radiolabeled (A) 3’ and (B) 5’ PatxA deletion constructs.  Refer to Figure 1 for 
schematics of the 3’ and 5’ deletion constructs.  Quantitative values of free probe are 
depicted below each lane.  Symbols: 100 ng specific PatxA unlabeled competitor (white 
star), 100 ng non-specific PspoVG unlabeled competitor (black star).  These data are 
representative of three separate experiments. 
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non-specific DNA-shift (Fig. 3-6A).  These results and the β-galactosidase activity results 
which showed a 14.9-fold increase in atxA promoter activity using the 85-bp atxA promoter-
lacZ fusion (Fig. 3-5B) suggest that sequences downstream of the P1 transcription start site 
are required for repressor protein(s) binding to the atxA promoter.   
 I further defined the repressor protein(s) binding site by testing 5’ deletions of the 
133-bp PatxA probe in EMSA experiments.  Specific DNA-shifts were observed using 5’ 
PatxA deletion probes of 97- and 74-bp (Fig. 3-6B).  These probes are partially or fully 
deleted for the AbrB binding site confirming that AbrB is not the protein causing the 
observed DNA-shifts (Fig. 3-1).  When the entire region upstream of P1 was deleted (60-bp 
PatxA probe), no specific DNA-shift was observed (Fig. 3-6B).  Take together, the deletion 
analyses suggest that the repressor protein(s) binding site is located between sequences 
from -13 to +31, relative to the P1 transcription start site (+1).              
 
3.2.5. A palindromic sequence required for repressor binding. 
 In silico analysis of the atxA promoter region using a program established by 
Technion Israel Institute of Technology (http://bioinfo.cs.technion.ac.il/) revealed an 
imperfect 9-bp palindrome separated by 1-bp (CAxGTCATC) within the sequences from -13 
to +31 (Fig. 3-7A).  Since palindromic sequences in DNA often represent regulatory protein 
binding regions, I questioned whether this region of DNA was necessary and sufficient for 
repressor protein(s) binding.  A radiolabeled 49-bp PatxA probe containing the 9-bp 
palindrome with an additional 15-bp on either side (native -13 to +36 [Fig. 3-7A]) was 
constructed to determine if this region of the atxA promoter was sufficient for binding of the 
atxA repressor protein(s).  EMSA experiments revealed that addition of soluble cellular 
extract to the 49-bp PatxA probe resulted in a specific DNA-shift.  Addition of excess 
unlabeled PatxA DNA, but not unlabeled PspoVG DNA, resulted in a diminished DNA-shift 
(Fig. 3-7B).  These results indicate that only sequences from -13 to +36 are required for  
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Figure 3-7. The atxA promoter region contains a 9-bp palindromic sequence required 
for repressor binding. (A) atxA promoter sequences from -13 to +36 relative to the P1 
transcription start site.  The palindromic sequence is denoted by bold, underlined letters.  
Nucleotides mutated using site-directed mutagenesis are denoted by lowercase, grey 
lettering. (B) EMSAs using cellular extract obtained from B. anthracis cultured in CACO3 + 
5% CO2 incubated with radiolabeled PatxA probes of sizes 49-bp or 171-bp.  Quantitative 
values of free probe are depicted below each lane. Symbols: PatxA unlabeled competitor 
(white star), PspoVG unlabeled competitor (black star).  These data are representative of 
three separate experiments. (C) β-galactosidase activity assays comparing atxA promoter 
activity in a parent strain (pink squares; pUTE843) versus a strain in which the native atxA 
promoter sequences from +14 to +22 were mutated (blue triangles; pUTE971).  Empty 
vector control (pHT304-18z) is denoted by yellow diamonds.  These data were averaged 
from three independent cultures.  
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repressor protein(s) binding to the atxA promoter region. 
 To confirm the specific requirement of the palindromic sequence for repressor 
binding, I tested a mutant containing nucleotide mutations within the palindrome in EMSAs.  
Transversion mutations were created from sequences +14 to +22 that contain 8- of the 9-bp 
within the downstream portion of the palindrome (Fig. 3-7A).  A specific DNA-shift was no 
longer apparent when the +14 to +22 mutated atxA promoter probe was used in EMSAs 
with soluble cellular extract (Fig. 3-7B) further confirming the importance of the palindrome 
for binding of the repressor protein(s).  I also observed a 7-fold increase in atxA promoter 
activity when the +14 to +22 mutated atxA promoter was transcriptionally fused to a 
promoterless lacZ gene and introduced into B. anthracis (Fig. 3-7C).  Together, these data 
defined a 49-bp region of the atxA promoter located near the P1 transcription start that 
contains a 9-bp palindrome required for binding of the atxA repressor protein(s).   
 
3.2.6. Anthrax toxin expression is increased when the putative atxA repressor 
binding site is mutated. 
 Saile et al. (131) reported previously that deletion of abrB resulted in early and 
increased toxin gene expression.  The increased toxin gene transcription is associated with 
elevated atxA promoter activity (68, 131).  Since atxA promoter activity increased 7-fold 
upon mutation of the palindrome (Fig. 3-7C), I mutated the native atxA promoter sequences 
from +14 to +22 (renamed atxA-up) and tested for a comparable increase in AtxA protein 
levels.  The steady state level of AtxA protein produced by the atxA-up mutant was 6.6-fold 
higher than that of the parent.  AtxA was not produced in an atxA-null strain and 
complementation of atxA resulted in 1.8-fold more AtxA than parent (Fig. 3-8A).  Western 
blot analysis of culture supernates revealed increased levels of the anthrax toxin proteins.  
The atxA-up mutant produced 5.4-, 8.9-, and 2-fold more LF, EF, and PA, respectively, than 
the parent strain (Fig. 3-8B).  An atxA-null mutant showed little to no anthrax toxin 
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production compared to parent, and complementation of the atxA-null strain showed 
restoration of the anthrax toxin proteins to levels above that of parent (Fig. 3-8B).  In total, 
these results showed increased expression of AtxA, LF, EF, and PA when a portion of the 
putative atxA repressor binding site was mutated suggesting derepression of atxA 
transcription. 
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Figure 3-8.  Increased AtxA expression results in elevated anthrax toxin (LF, EF, and 
PA) production. Production of (A) AtxA and (B) LF, EF, and PA by parent and mutant B. 
anthracis strains. Culture samples were obtained during transition phase (4h) of growth. (A) 
Samples were subjected to SDS-PAGE and Western blot analysis using rabbit α-AtxA 
antibody raised against B. anthracis AtxA or mouse α-RNA Pol β antibody raised against E. 
coli RNA Pol β. (B) Samples were subjected to Slot blot Western analysis using rabbit α-LF, 
rabbit α-EF, and goat α-PA antibodies raised against B. anthracis proteins.  These data are 
representative of three separate experiments. 
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3.3. Discussion 
 An atxA-null strain produces little to no anthrax toxin and is avirulent in a murine 
model for anthrax disease demonstrating the necessity of atxA for B. anthracis virulence 
(36).  Transcription factors that impact atxA expression both at the transcriptional and post-
translational level have been shown to affect B. anthracis virulence.  The carbon catabolite 
protein CcpA, which senses and responds to carbon availability in Gram-positive bacteria, 
positively affects atxA transcription indirectly by an unknown mechanism.  Deletion of the 
ccpA gene results in decreased atxA transcription and attenuated virulence in a 
subcutaneous murine model of anthrax disease (32, 170).  The pleiotropic transcription 
regulator CodY, well characterized in B. subtilis as a regulator that responds to cell energy 
and nutrient status (124, 141), modulates AtxA stability in batch culture.  A codY-null mutant 
exhibits decreased AtxA protein levels and is avirulent in a subcutaneous model of anthrax 
disease (168).  The mechanism for CodY regulation of AtxA is unknown; however, it has 
been proposed that deletion of codY results in the production of a protease, chaperone, or 
adaptor protein that directly influences AtxA stability.  
 In this chapter, I expanded on previous investigations of transcriptional control of 
atxA by examining cis-acting elements and trans-acting factors that directly influence atxA 
expression.  Transcription initiation relies on promoter recognition by RNA polymerase 
(RNAP).  The sigma subunit of RNAP confers promoter specificity and directs RNAP to its 
target gene(s) while the α-subunits of RNAP contribute to promoter recognition by 
interacting with a specific A+T-rich sequence, referred to as the UP-element, located 
upstream of the -35 sigma factor consensus.  The binding of RNAP α-subunits to the UP-
element stabilizes and strengthens RNAP binding (12, 62, 129).  Here, I showed that atxA 
transcription requires sequences resembling the SigA consensus and an UP-element for 
RNAP.        
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 There are conflicting reports regarding regulation of atxA by the alternative sigma 
factor SigH.  When an atxA promoter–lacZ reporter construct was cloned into the 
heterologous host B. subtilis, atxA promoter activity was controlled by SigH in an AbrB-
dependent manner (151).  Bongiorni et al. (14) examined atxA promoter activity in the B. 
anthracis Sterne-like strain 34F2 and showed that atxA transcription did not require SigH.  
Hadjifrangiskou et al. (68) showed previously that SigH positively controls atxA transcription 
in an AbrB-independent manner in the Sterne-like strain UM44.  In addition, Hadjifrangiskou 
et al. (68) reported that SigH-RNAP transcribes an atxA promoter template in vitro.  
However, based on subsequent work and data presented here, I believe the in vitro 
transcript generated using SigH-RNAP resulted from end-to-end transcription of the DNA 
template, followed by degradation to a shorter RNA transcript.  Taken together, these data 
indicate that SigH controls atxA by an unknown mechanism that varies among strains.     
 In this work, I have demonstrated that in addition to AbrB, another trans-acting 
protein(s) specifically binds the atxA promoter and represses transcription.  My data 
indicate that the atxA trans-acting repressor protein(s) specifically binds to a 9-bp 
palindrome located immediately downstream of P1 from sequences +3 to +21 
(CAgGTCATC – 1-nt spacer – GATGACaTG).  Using the in silico database PRODORIC 
(108), I searched for known transcription factors that could potentially interact with the 9-bp 
palindrome.  The search did not reveal any candidate transcription factors so I broadened 
the search parameters.  Instead of using the 9-bp palindrome sequence alone, the entire 
49-bp atxA promoter region required for binding of the trans-acting repressor protein(s) was 
used in an in silico search.  The search revealed potential interaction of the Pseudomonas 
aeruginosa -10 sigma factor AlgU (99) and the Escherichia coli aerobic respiration control 
protein ArcA (80).   
 The P. aeruginosa AlgU protein is a sigma factor with predicted sequence similarity 
to the alternative sigma factor SigH of Bacillus species (99).  A search for AlgU homologues 
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in B. anthracis revealed several sigma factors.  Since I have already determined that the 
putative SigA consensus was required for atxA promoter activity, and the potential binding 
site for AlgU is downstream of this region, I ruled out AlgU homologues as the potential 
atxA trans-acting repressor binding protein(s).  The E. coli ArcA protein is a DNA-binding 
response regulator that is part of the ArcAB two-component system.  ArcA is activated by 
ArcB when oxygen availability is low, and represses a variety of aerobic enzymes (65).  A 
search for B. anthracis protein homologues of E. coli ArcA revealed more than 30 proteins 
annotated as DNA-binding response regulators that contained anywhere from 
approximately 50-60% similarity.  Without any additional information, I am unable to 
prioritize these genes as potential candidates for regulators of atxA.    Therefore, the in 
silico analysis revealed that no known trans-acting factors in the database were likely 
candidates for specific interaction with the atxA promoter region. 
 To determine if other B. anthracis promoter sequences contained the 9-bp 
palindrome and were therefore regulated in a manner similar to atxA, I employed an in silico 
search using the PRODORIC database (108).  The in silico analysis revealed 14 potential 
regions throughout the B. anthracis chromosome that contain an imperfect version of the 9-
bp palindrome.  Other than the atxA promoter on pXO1, regions containing the 9-bp 
palindrome were not identified on plasmid sequences.  A majority of the genes in which the 
imperfect 9-bp palindrome was found upstream of the start codon do not have gene 
annotations.  One of the few annotated genes, codY, was of particular interest considering 
that CodY post-transcriptionally modulates AtxA protein levels (168).  I performed EMSAs 
using the codY promoter region and cellular extract from B. anthracis; however, no specific 
DNA-shift was observed (Fig. 3-9).  These results suggest that the atxA-associated 
palindrome is a unique binding site for the repressor protein(s), but do not rule out the 
possibility of interactions with the other 13 palindromic sequences identified in the in silico 
search.   
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 Mechanisms by which trans-acting factors control transcription are in part 
associated with the location of the binding site in the promoter region.  Typically, the 
location of a trans-acting binding site determines whether the given transcription factor will 
activate or repress gene expression.  The master response regulator Spo0A can activate or 
repress transcription of its target genes depending on the location of its cognate ‘0A’ box 
(107, 144, 147, 152).  Typically, Spo0A stimulates transcription when ‘0A’ boxes are located 
upstream of the transcription start site and represses target genes when ‘0A’ boxes are 
located downstream of the start site.  Active Spo0A binds to sequences upstream of the 
spoIIG operon transcriptional start site enabling RNAP to efficiently contact the -10 
consensus sequence and initiate steps subsequent to closed-complex formation (130).  In 
contrast, Spo0A represses abrB transcription by binding downstream of the abrB P1 and P2 
transcription start sites likely preventing the progression of RNAP from P1 and blocking 
binding of RNAP to P2 (119, 147).  Another example of a transcription factor that uses the 
location of its cognate binding site to activate or repress its target genes is the carbon 
catabolite protein CcpA.  CcpA, with its accessory protein HPr, activates transcription of the 
group A streptococcus master virulence regulator Mga by binding to a cre-element located 
upstream of the P1 transcription start site (5).  In contrast, CcpA-HPr represses the 
alternative carbon metabolism genes acsA, araB, and amyE by binding to cre-elements 
located downstream of the each transcription start site (55, 170, 181). 
Here I showed that the atxA repressor protein(s) requires sequences within a 9-bp 
palindrome located immediately downstream of the atxA P1 transcription start site.  
Mutation of the 9-bp palindrome in the native atxA promoter region resulted in derepression 
of atxA and elevated AtxA and anthrax toxin production.  My working model is that the atxA 
repressor protein(s) likely prevents the progression of RNAP from P1 and/or interferes with 
RNAP binding to the atxA promoter region.  
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Figure 3-9.  The trans-acting repressor protein(s) does not bind the codY promoter 
palindrome.  B. anthracis sigH/abrB-null soluble cellular extract mixed with radiolabeled 
49-bp PcodY and 49-bp PatxA probes.  Soluble cellular extract was obtained from cells 
cultured in CACO3 + 5% CO2.  EMSAs using radiolabeled PcodY resulted in a non-specific 
mobility shift (left side of gel) whereas radiolabeled PatxA resulted in a specific mobility shift 
(right side of gel).  Unlabeled competitors include 49-bp PatxA (white star), 187-bp 
Pspo0VG (black stars), and 49-bp PcodY (dotted star).  These data are representative of 
two separate experiments using either ∆sigH/abrB (UT291) or parent (ANR-1) cellular 
extract.  
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Chapter IV 
AtxA modulates B. anthracis development 
 
 
 
 
 
 
 
 
 
NOTE:  Maureen Ty helped perform experiments related to sample preparation for AtxA 
and LF Western blot analysis.  Gregory L. Shipley, Ph.D., and the Quantitative Genomics 
Core Laboratory at The University of Texas Health Science Center Houston performed the 
RT-qPCR assays and data normalization. 
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4.1. Introduction 
 Sporulation is a developmental process that members of the Bacillus genus undergo 
in response to unfavorable, nutrient deplete growth conditions.  The spore is metabolically 
inactive, resistant to environmental stresses, and can survive until conditions are favorable 
for germination into a vegetative cell.  The process of sporulation is energy exhaustive; 
therefore, is considered a last resort of survival for the bacterium.  In the archetype Bacillus 
species, B. subtilis, the developmental process of sporulation has been well-studied.  
Nutrient deprivation is sensed by a multi-component signal transduction phosphorelay 
resulting ultimately in phosphorylation of the master response regulator Spo0A, and a 
commitment to sporulation (reviewed in (121)).  B. anthracis, the etiological agent of 
anthrax disease, possesses orthologues of the signal transduction phosphorelay that 
enable the bacterium to sporulate in a manner similar to that of B. subtilis (15, 16, 21, 144). 
 The B. anthracis spore constitutes the infectious form of the bacterium.  B. anthracis 
infection results in one of three forms of anthrax disease, cutaneous, gastrointestinal, or 
inhalation, depending on the route of infection.  The most well-studied form of anthrax 
disease is inhalation anthrax.  Upon entry into the lungs, B. anthracis spores are 
phagocytosed by resident alveolar macrophages and dendritic cells, which serve as 
vehicles for transit to the regional lymph nodes (8, 34, 39, 106, 128).  Spores that survive 
the initial immune response are capable of germinating into vegetative bacilli and 
disseminating throughout the body.  The bacilli do not initiate sporulation inside the host.   
 The master virulence regulator of B. anthracis, AtxA, is required for optimal 
expression of the anthrax toxins and capsule which promote in vivo survival of the 
bacterium.  An atxA-null B. anthracis strain is avirulent in a murine model of anthrax 
disease (36).  The structural genes for anthrax toxin, pagA, lef, and cya, located on pXO1, 
and the capsule biosynthetic operon, capBCADE, located on pXO2, are positively 
controlled by AtxA (26, 36, 40, 50, 67, 84, 87, 97, 101, 112, 113, 136, 165, 166).  
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Transcription of the anthrax toxin and capsule genes is enhanced by host related cues such 
as elevated CO2.  In the absence of elevated CO2 and/or atxA, little to no anthrax toxin or 
capsule is produced by B. anthracis (9, 18, 28, 33, 36, 50, 70, 75, 77, 87, 101, 137, 165).  
B. anthracis evades the host immune response primarily by the production of anthrax toxin 
and a poly-γ-D-glutamic acid capsule.  
 In this chapter, I show that anthrax toxin production and B. anthracis development 
are inversely related.  I also demonstrate that there is a condition-dependent expression of 
AtxA that inversely corresponds with the production of anthrax toxin.  To assess 
phenotypes attributed to altered expression of AtxA in different culture conditions, I mutated 
a regulatory region within the atxA promoter of the genetically complete Ames strain.  Upon 
mutation of the atxA promoter region, I found that AtxA expression and sporulation are not 
significantly affected in toxin-inducing conditions.  Conversely, AtxA is overexpressed in 
sporulation conditions and a marked decrease in spore formation is observed.  The AtxA-
associated sporulation defect is dependent upon the pXO2 gene pXO2-61, predicted to 
encode a protein homologous to the sensor domain of sporulation sensor histidine kinases. 
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4.2. Results 
 
4.2.1. B. anthracis anthrax toxin production and sporulation are inversely related 
 B. anthracis, like all other Bacillus species, develops into environmentally resistant 
spores in response to nutrient deprivation.  Limitation of nutrients can be modeled in batch 
culture by incubating cells in media for extended periods of time without nutrient 
supplementation.  I sought to examine sporulation of B. anthracis using different culture 
conditions: a rich medium incubated in air (PA-air), or a semi-defined minimal medium 
containing dissolved bicarbonate and incubated in 5% CO2 (CACO3).  The latter growth 
condition is thought to model physiologically relevant conditions encountered by the 
bacterium during infection whereas the former is believed to model environmental 
conditions outside the host.  B. anthracis growth rates were similar when cultured in PA-air 
or CACO3 (Fig. 4-1A).  When the cells were cultured in PA-air, there was an increase in the 
percentage of heat-resistant CFU over time, indicative of sporulation.  In contrast, there 
were little to no heat-resistant CFU obtained for cells cultured in CACO3 indicating that this 
growth condition is not conducive for sporulation (Fig. 4-1A).  
 In addition to assessing sporulation, I performed Westerns to examine both AtxA 
and Lethal Factor (LF) protein levels when cultured in the two growth conditions. LF 
expression peaked during the transition into stationary phase and protein levels decreased 
within stationary phase when cultured in CACO3 (Fig. 4-1B).  Transition phase occurs within 
four hours after inoculation of cells from an overnight culture using our culture methods.  
Pflughoeft et al. (120) showed previously that degradation of LF during stationary phase is 
due to the presence of B. anthracis extracellular proteases that target the anthrax toxin 
proteins.  Conversely, LF synthesis was not observed during any growth phase when B. 
anthracis was cultured in PA-air (Fig. 4-1B).  In concordance with the absence of LF 
production in PA-air, AtxA levels were minimal and decreased over time when B. anthracis 
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Figure 4-1. Toxin production and sporulation are inversely related. (A) Growth curve 
and heat-resistance CFU determination of Ames cultured in toxin-inducing (CACO3 +5% 
CO2; solid line/squares) and sporulation (PA-air; hashed line/diamonds) conditions. (B) 
Production of LF in sporulation and toxin-inducing conditions.  Cell-free supernatants were 
obtained from early exponential (2h), transition (4h), and stationary (7h) phases of growth 
and subjected to Western blot analysis using rabbit α-LF antibody. Protein loads were 
normalized to OD600. (C) Production of AtxA in sporulation and toxin-inducing conditions.  
Samples were obtained from early exponential (2h), transition (4h), and stationary (7h) 
phases of growth and subjected to Western blot analysis using rabbit α-AtxA antibody. 
Protein loads were normalized to OD600 values per sample time point.  These data are 
representative of three separate experiments. 
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was cultured in PA-air (Fig. 4-1C).  The opposite was true when B. anthracis was cultured 
in CACO3, AtxA protein levels increased as the cells transitioned into stationary phase (Fig. 
4-1C). Together, these results demonstrate an inverse relationship between sporulation and 
anthrax toxin production.  Furthermore, the results indicate that there is a condition-
dependent inverse expression of AtxA.  B. anthracis sporulates but produces little to no 
AtxA and LF in sporulation conditions (PA-air), whereas when cultured in toxin-inducing 
conditions (CACO3 + 5% CO2), B. anthracis does not sporulate but produces AtxA and LF.      
 
4.2.2. Misregulation of atxA results in a pXO2-dependent sporulation defect 
 I reported in Chapter 3 the creation of a B. anthracis Sterne-like ANR-1 (pXO1+, 
pXO2-) mutant (ANR-1 atxA-up) that overexpresses AtxA in toxin-inducing conditions.  The 
ANR-1 atxA-up mutant contains specific nucleotide mutations within the native atxA 
promoter region putative trans-acting repressor binding site (see section 3.2.6).  In order to 
assess the impact of altered atxA regulation in the genetically complete B. anthracis Ames 
(pXO1+, pXO2+) strain, I created an Ames atxA-up mutant in the same manner as the 
ANR-1 atxA-up mutant (see section 2.2).  Sporulation of the Ames atxA-up mutant was 
significantly impaired whereas no sporulation defect was observed in the ANR-1 atxA-up 
mutant (Fig. 4-2) indicating that the sporulation defect was pXO2-dependent.   
 In an attempt to determine the extent of the pXO2-dependent sporulation defect in 
the Ames atxA-up mutant, I performed a time course experiment where B. anthracis 
sporulation was examined using phase-contrast microscopy.  B. anthracis Ames and Ames-
derivatives were cultured in sporulation conditions (PA-air) over a 48 hour time period (Fig. 
4-3).  The B. anthracis parent and atxA-null strains contained visible endospores by 7 hours 
of growth.  The cells were in stationary phase of growth at this time point (Fig. 4-1A).  
Within 24 hours after initiation of the time course, several free floating spores were 
apparent in both the parent and atxA-null strain backgrounds.  The abundance of free  
 71 
 
 
 
 
 
 
 
 
Figure 4-2.  An Ames atxA-up mutant is impaired for spore formation.  Phase contrast 
microscopy showing representative B. anthracis (A) ANR-1 and (B) Ames cultures 
incubated in sporulation conditions (PA – air) after 48 hours.   
 
 
 
 
 
 
 72 
 
 
 
        
 
Figure 4-3. Sporulation of B. anthracis when cultured in sporulation conditions (PA-
air). Phase contrast microscopy showing B. anthracis sporulation patterns of parent and 
mutant strains in batch culture over a 48 hour time course.  These data are representative 
of three separate experiments.  
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floating spores increased by 48 hours.  In comparison, the Ames atxA-up mutant displayed 
a visible delay and decreased efficiency in sporulation.  Several vegetative bacilli were 
present throughout the time course and free floating spores were only visible after 48 hours 
of growth (Fig. 4-3).  This appearance of free spores was delayed by 24-hours compared to 
the parent and atxA-null strains.  To ensure that the sporulation defect was attributed to the 
deregulation of atxA and was not associated with misregulation of other genes controlled by 
the putative trans-acting repressor protein, I deleted atxA in the Ames atxA-up mutant 
background.  This strain contained the mutated atxA promoter region but lacked the atxA 
gene (referred to as ∆atxA/atxA-up).  The sporulation defect observed in the Ames atxA-up 
mutant was relieved upon deletion of atxA in the ∆atxA/atxA-up mutant (Fig. 4-4).  These 
results indicate that the sporulation defect seen in the Ames atxA-up mutant was atxA-
dependent. 
 Next, I sought to investigate the mechanism behind the atxA- and pXO2-dependent 
sporulation defect.  Previously reported transcriptional profiling results from Bourgogne et 
al. (18) showed that a pXO2 gene, pXO2-61, was positively regulated 54-fold by atxA.  
pX02-61 exhibits high sequence similarity to the signal sensor domain of the BA2291 
sporulation sensor histidine kinase which is a key component of the sporulation 
phosphorelay (174).  Overexpression of pXO2-61 in a Sterne-like strain resulted in a 
marked decrease in sporulation that was suppressed by deletion of the sensor histidine 
kinase BA2291 (174).  Therefore, I questioned whether the decreased sporulation observed 
in the Ames atxA-up mutant was a result of pXO2-61 overexpression due to derepression 
of atxA.  To test the affect of pXO2-61 on sporulation, I deleted pXO2-61 in the Ames-
derived strains and monitored sporulation over a 48 hour time course using phase-contrast 
microscopy.  A ∆pXO2-61 strain displayed a sporulation pattern similar to both the parent 
and atxA-null strain, and the double ∆pXO2-61/atxA-up mutant exhibited an identical 
sporulation profile (Fig. 4-3).  These results indicate that the Ames atxA-up sporulation  
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Figure 4-4.  The atxA-up sporulation defect is atxA-dependent.  Phase contrast 
microscopy showing representative cultures of parent and mutant B. anthracis strains 
incubated in sporulation conditions (PA – air) after 48 hours. 
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defect was both atxA- and pXO2-61-dependent.   
 Phase-contrast microscopy provides a qualitative assessment of sporulation.  I 
wanted to determine if the observed spores were fully developed, so the number of total 
heat-resistant CFU was quantified.  To this end, aliquots obtained from the B. anthracis 24-
hour cultures were incubated at 65°C for 45 min and plated to determine the total number 
of heat-resistant CFU of parent and mutant strains when cultured in sporulation conditions.  
The parent, ∆atxA, ∆pXO2-61, and ∆pXO2-61/atxA-up strains all contained approximately 
108 heat-resistant CFU whereas the Ames atxA-up mutant produced 1000-fold fewer heat-
resistant CFU (~105) (Table 4-1).  These results are in agreement with my interpretation of 
the phase-contrast microscopy data.  Taken together, the results indicate that the Ames 
atxA-up mutant sporulation delay is pXO2-61-dependent and suggest that pXO2-61 is 
overexpressed in the Ames atxA-up strain background.   
 
4.2.3. Increased expression of AtxA leads to elevated pXO2-61 transcription 
 AtxA protein levels diminished when cultures of the Ames parent strain grown in 
sporulation conditions transitioned from exponential to stationary phase (Fig. 4-1C).  I 
wanted to determine if the steady state level of AtxA changed similarly in cultures of the 
Ames atxA-up and pXO2-61 mutants.  As was true for the parent strain, the ∆pXO2-61 
mutant showed a decrease in AtxA levels from early exponential (T2) to stationary phase 
(T7) of growth (Fig. 4-5A).  In contrast, AtxA protein levels were elevated 4.5-fold in the 
Ames atxA-up and 4.7-fold in the ∆pXO2-61/atxA-up mutants compared to parent.   AtxA 
was not expressed in the atxA-null strain.  The increased expression of AtxA was most 
evident at transition (T4) and stationary (T7) phases of growth (Fig. 4-5A).  A decrease in 
AtxA levels was apparent in the ∆pXO2-61/atxA-up mutant compared to the Ames atxA-up 
mutant at stationary phase (T7) when the ∆pXO2-61/atxA-up mutant had begun to 
sporulation (Fig. 4-3 and Fig. 4-5A).   
 76 
 
 
 
 
Figure 4-5. AtxA protein abundance and pXO2-61 transcript levels in sporulation 
conditions (PA-air).  (A) AtxA protein levels in parent and mutant strain backgrounds.  
Culture samples were obtained during early exponential (T2), transition (T4), and stationary 
(T7) phases of growth. Samples were subjected to Western blot analysis using rabbit α-
AtxA antibody. Protein loads were determined based on OD600 values and normalized to 
cross-reactive products from α-AtxA or α-RNAP-β blots.  These data are representative of 
three separate experiments.  (B) RT-qPCR of pXO2-61 transcripts normalized to gyrB in 
parent and mutant strains.  These data represent average values of detectable transcripts 
from three independent cultures.    
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 Since antibodies for pXO2-61 are not available, I performed RT-qPCR on pXO2-61 
transcripts in the various Ames-derivatives at the transition phase of growth (T4).  pXO2-61 
transcripts were elevated approximately 5-fold in the Ames atxA-up mutant compared to 
parent and 26-fold compared to the atxA-null strain (Fig. 4-5B).  There was no detectable 
pXO2-61 transcript in the single or double ∆pXO2-61 strain backgrounds.  These results 
indicate that the overexpression of AtxA resulted in elevated pXO2-61 transcription and a 
corresponding pXO2-61-dependent sporulation defect. 
 
4.2.4. B. anthracis sporulates when cultured in toxin-inducing conditions 
B. anthracis cultured in toxin-inducing conditions (CACO3 + 5% CO2) for 10 hours 
resulted in few heat-resistant CFU, suggesting that the cells were not developing into 
spores (Fig. 4-1A).  However, following prolonged incubation, phase-contrast microscopy 
revealed cells harboring spores (Fig. 4-6).  There were visible endospores forming in the 
parent strain by 24 hours with several free floating spores by 48 hours.  Sporulation of the 
Ames atxA-up mutant was virtually identical to that of the parent strain background.  The 
atxA-null strain produced phase-bright endospores earlier than parent and the Ames atxA-
up mutant at the 12 hour time point.  Both the single ∆pXO2-61 and double ∆pXO2-
61/atxA-up mutants were the first to develop endospores at the 7-hour time point.   
 Quantitative determination of sporulation showed that there were 1- to 2-log fewer 
heat-resistant CFU when cells were cultured in toxin-inducing versus sporulation conditions.  
There were 106-107 heat-resistant CFU in toxin-inducing conditions compared to 108 heat-
resistant CFU when cells were cultured in sporulation conditions (Table 4-1).  Nonetheless, 
parent and mutant strains were capable of sporulating in toxin-inducing conditions.  In 
contrast to cells cultured in sporulation conditions, the atxA-up mutant did not have a drastic 
sporulation defect compared to parent in toxin-inducing conditions (Fig. 4-3 and Fig 4-5).  
Overall, these results suggest that the impact of altered AtxA expression is greater in 
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Figure 4-6. Sporulation of B. anthracis when cultured in toxin-inducing conditions 
(CACO3 + 5% CO2).  Phase contrast microscopy showing B. anthracis sporulation patterns 
of parent and mutant strains in batch culture over a 48 hour time course.  These data 
represent three separate experiments. 
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sporulation conditions compared to toxin-inducing conditions.    
 Toxin-inducing conditions are optimal for B. anthracis capsule production (40, 42, 
64, 97).  I wanted to determine if altered expression of atxA and/or deletion of pXO2-61 had 
any impact on capsule production, and whether the formation of capsule affected 
sporulation.  Using India Ink exclusion assays, I examined capsule production in the various 
Ames-derivatives.  Capsule production was unaffected in the Ames atxA-up, ∆pXO2-61, 
and ∆pXO2-61/atxA-up mutant strains indicating that misregulation of atxA, and deletion of 
pXO2-61, does not impact capsule formation.  These results also indicate that capsule 
production does not inhibit spore development (Fig. 4-7). 
  
4.2.5. AtxA and pXO2-61 levels are unaffected by atxA misregulation in toxin-
inducing conditions 
 The steady state level of AtxA in the parent background increased from early 
exponential (T2) to stationary phase (T7) of growth in toxin-inducing conditions (Fig. 4-1C).  
I sought to determine if AtxA protein levels would vary in the atxA-up and pXO2-61 mutant 
derivatives when cultured in toxin-inducing conditions.  There was a minimal difference in 
AtxA protein levels between the parent, atxA-up mutant, and the double ∆pXO2-61/atxA-up 
strains (Fig. 4-8A).  These results do not correlate with the increased expression of AtxA in 
the ANR-1 atxA-up mutant when cultured in toxin-inducing conditions suggesting that 
factors on pXO2 also impact AtxA (Fig. 3-8).  Additional evidence suggestive of pXO2 
regulation of AtxA is apparent in the ∆pXO2-61 strain background.  AtxA protein levels 
diminished over time when pXO2-61 was deleted (Fig. 4-8A).  The observed decrease in 
AtxA levels in the ∆pXO2-61 strain is similar to the pattern of AtxA expression when 
cultured in sporulation conditions (Fig. 4-1C).  An atxA-null mutant did not express AtxA 
(Fig. 4-8A).  
 pXO2-61 transcript levels were also determined in the various Ames-derivatives at 
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Figure 4-7. Capsule production of B. anthracis parent and mutant strains in toxin-
inducing conditions (CACO3 + 5% CO2).  Qualitative analysis of capsule production using 
India ink exclusion assays.  These data represent three separate experiments. 
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the transition phase of growth (T4) when cultured in toxin-inducing conditions.  pXO2-61 
transcripts were comparable in the parent and atxA-up mutant with less than a 2-fold 
change in relative transcript levels (Fig. 4-8B).  There was an approximate 52-fold decrease 
in pXO2-61 transcript levels in the atxA-null mutant compared to parent and the atxA-up 
mutant.  No pXO2-61 transcripts were detected in the single or double ∆pXO2-61 strains.  
Strains with decreased pXO2-61 transcripts (∆pXO2-61, ∆pXO2-61/atxA-up, atxA-null) 
sporulated earlier than the B. anthracis strains expressing pXO2-61 (parent, Ames atxA-
up).  In total, these results suggest differential control of AtxA when cultured in toxin-
inducing versus sporulation conditions and also implicate pXO2-61 in control of atxA 
expression.   
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Figure 4-8. AtxA protein abundance and pXO2-61 transcript levels in toxin-inducing 
conditions (CACO3 + 5% CO2).  (A) AtxA protein levels in parent and mutant strain 
backgrounds.  Culture samples were obtained during early exponential (T2), transition (T4), 
and stationary (T7) phases of growth. Samples were subjected to Western blot analysis 
using rabbit α-AtxA antibody. Protein loads were determined based on OD600 values and 
normalized to Ponceau S stained membranes.  These data are representative of three 
separate experiments.  (B) RT-qPCR of pXO2-61 transcripts normalized to gyrB in parent 
and mutant strains.  These data represent an average of three independent experiments. 
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Table 4-1. Total heat-resistant CFU/ml of parent and mutant strains cultured in 
sporulation and toxin-inducing conditions.   
 Parent ∆atxA atxA-up ∆pXO2-61 ∆pXO2-61/ atxA-up 
PA - air 2.4x108 2.2x108 6.3x105 2.4x108 1.5x108 
CACO3 - 5% CO2 4.7x106 4.9x106 1.1x107 9.3x106 1.1x107 
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4.3. Discussion 
 In this chapter, I showed that B. anthracis sporulation and anthrax toxin production 
were inversely related in a condition-dependent manner.  The inverse relationship between 
B. anthracis sporulation and anthrax toxin production is physiologically significant for 
anthrax disease.  During infection, B. anthracis remains in the vegetative cell state and 
synthesizes anthrax toxin proteins and other factors that facilitate pathogenesis; sporulation 
does not occur.  Collection of cerebrospinal fluid and blood from B. anthracis infected 
mammals shows the presence of infiltrating vegetative cells, not spores.  Conversely, when 
vegetative cells are exposed to environments outside of the host, toxins are not produced 
and B. anthracis sporulates efficiently (23, 106, 128, 133).  Toxin synthesis and sporulation 
in B. anthracis are linked by common transcriptional regulators: the master response 
regulator Spo0A, the transition state regulator AbrB, and the alternative sigma factor SigH.  
Spo0A, AbrB, and SigH have been well-characterized in the archetype Bacillus species, B. 
subtilis, and are crucial for the appropriate regulation of development/sporulation (reviewed 
in (121)).  The B. anthracis orthologues perform similar roles, but in addition, control atxA 
expression (15, 16, 21, 68, 131, 144, 151). 
 AtxA positively controls transcription of the structural genes for the anthrax toxin 
proteins, located on pXO1, the capsule biosynthetic operon, carried on pXO2, and multiple 
other pXO1, pXO2, and chromosomal genes (18, 36, 40, 50, 67, 75, 77, 84, 87, 97, 101, 
112, 113, 136, 165, 166).  Here I demonstrated that AtxA protein levels not only impacted 
anthrax toxin production but also affected B. anthracis development in a growth condition-
dependent manner.  My results showed an inverse expression of AtxA in toxin-inducing 
versus sporulation conditions.  The steady state level of AtxA increased from early 
exponential to stationary phase of growth in toxin-inducing conditions whereas AtxA protein 
levels were minimal and decreased over time in sporulation conditions.  Altering the 
regulation of atxA by mutating the atxA promoter region resulted in overexpression of AtxA 
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and a marked decrease in B. anthracis sporulation when cultured in sporulation conditions.  
Taken together, these results suggest that AtxA plays a role in B. anthracis spore 
development. 
 Previous reports have implicated atxA in proper spore development, but never 
directly shown AtxA involvement.  Deletion of pXO1 or atxA itself results in more efficient 
spore formation when cultured in rich media (75, 158).  In addition, Mignot et al. (102) 
reported that expression of a B. thuringiensis plcR gene in a B. anthracis strain containing 
atxA resulted in a significant decrease in sporulation, a phenotype that was rescued by 
deletion of atxA.  PlcR is a pleiotropic transcriptional regulator in the B. cereus group 
members that controls multiple genes, several of which are associated with pathogenesis 
(1, 59, 91).  Most B. cereus group member species, except B. anthracis, contain a 
functional plcR gene.  The B. anthracis plcR gene contains a species-specific nonsense 
mutation rendering it inactive (102).  Typical B. cereus group members do not possess 
and/or express both atxA and plcR suggesting that mutation of plcR resulted in a selective 
advantage for B. anthracis.  The final line of evidence suggesting atxA is involved in spore 
development is that overexpression of a highly atxA-regulated gene, pXO2-61, in a Sterne-
like strain of B. anthracis led to a marked decrease in sporulation (174). 
 pXO2-61 bears homology to the signal sensor domain of one of the major B. 
anthracis sporulation sensor histidine kinases, BA2291.  B. anthracis sporulation initiates 
when a signal is sensed by sensor histidine kinases (i.e. BA2291) which further transduce 
the signal through a multi-component signal transduction phosphorelay (reviewed in (121)).  
Using phosphotransfer experiments, White et al. (174) demonstrated that BA2291 
possesses phosphatase activity and can remove phosphate from Spo0F, the initial 
response regulator of the phosphorelay.  Therefore, it has been proposed that when 
BA2291 is not bound by an activating signal it converts from a kinase to a phosphatase that 
negatively impacts sporulation at the Spo0F level.  The sporulation defect observed as a 
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result of pXO2-61 overexpression, in a Sterne-like strain of B. anthracis, was suppressed 
when BA2291 was deleted indicating that the phenotype was BA2291-dependent (174).  It 
was proposed that overexpression of pXO2-61 titrates signal away from BA2291 resulting 
in conversion of BA2291 from a kinase to a phosphatase inhibiting the sporulation 
phosphorelay.  Bourgogne et al. (18) demonstrated that pXO2-61 is strongly regulated by 
AtxA.  Transcriptional profiling showed a 54-fold decrease in pXO2-61 expression when 
atxA was deleted.  My results indicated that increased expression of AtxA led to elevated 
pXO2-61 transcription which resulted in delayed and decreased sporulation.  These data 
provide evidence for coordinate regulation of toxin gene expression and sporulation by 
AtxA.   
    I also demonstrated that B. anthracis sporulation during culture in toxin-inducing 
conditions is delayed and less efficient than the sporulation that occurs during culture in 
traditional sporulation conditions.  These results would suggest that B. anthracis has the 
capability of sporulating in vivo.  Nevertheless, sporulation has not been observed in vivo.  
This is likely due to AtxA-dependent increased transcription of pXO2-61.  AtxA is required 
for the expression of anthrax toxin and capsule enabling in vivo survival of B. anthracis.  
Here I have demonstrated an additional function of AtxA is to modulate sporulation of B. 
anthracis by controlling pXO2-61 transcript levels. Comparison of pXO2-61 transcript levels 
in conditions conducive (sporulation conditions) and not conducive (toxin-inducing) for 
sporulation, I saw that pXO2-61 transcripts were elevated approximately 35-fold in non-
sporulation conditions (toxin-inducing).  I propose that elevated expression of a known 
AtxA-regulated sporulation inhibitor, pXO2-61, is a mechanism developed by B. anthracis to 
prevent premature sporulation during anthrax disease.    
 I only observed sporulation of B. anthracis in toxin-inducing conditions following 
prolonged incubation.  Unlike conditions encountered in host tissues, nutrients become 
deplete over extended periods of time in batch culture.  In addition, frequent removal of the 
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B. anthracis cultures from the CO2 environment to obtain samples may have decreased 
CO2 signaling that is required for optimal AtxA activity (70).  Examining B. anthracis 
sporulation in closed vessels during growth in toxin-inducing conditions may be more 
representative of the host environment.   
 Environment-appropriate control of the key regulator of Listeria monocytogenes 
pathogenesis, PrfA, was shown to be critical for optimal survival of the bacterium inside and 
outside of the host (20).  Similar to B. anthracis, L. monocytogenes is a saprophytic soil 
bacterium that has adapted to life within mammalian host cells (63, 81).  Constitutive 
activation of PrfA resulted in a hyper-virulent phenotype in mice; however, as a 
consequence, L. monocytogenes was no longer suited for ex vivo growth.  Improper 
regulation of PrfA tipped the balance toward survival of L. monocytogenes in the host 
versus the environment.  My work provides evidence for an AtxA-dependent mechanism of 
B. anthracis survival inside and outside the host.  AtxA is required for anthrax toxin and 
capsule production enabling survival within the host whereas AtxA is not required for spore 
formation.  Instead, the expression of AtxA dampens sporulation of B. anthracis.  The 
inappropriate timing of B. anthracis sporulation during infection could be detrimental to the 
bacterium and result in increased vulnerability to the host immune response.  In addition, 
inhibition of sporulation outside the host could make the bacterium more susceptible to 
environmental stresses such as heat, desiccation, and antimicrobials produced by other soil 
bacteria.  To my knowledge, this is the first report showing a direct relationship between 
AtxA production and B. anthracis development.       
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Chapter V 
The developmental regulators AbrB, Spo0A, and SigH differentially 
regulate atxA expression in a strain-dependent manner 
 
 
 
 
 
 
 
 
NOTE:  Malik Raynor and Prabhat Dwivedi, Ph.D., performed the animal injections.  Jason 
Rall, Ph.D., performed experiments related to quantification of atxA transcript levels.  
Gregory L. Shipley, Ph.D., and the Quantitative Genomics Core Laboratory at The 
University of Texas Health Science Center Houston performed the RT-qPCR assays and 
data normalization. 
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5.1. Introduction  
 B. anthracis produces two critical virulence factors, anthrax toxin and capsule, to 
escape and evade the host immune response during infection.  The structural genes for 
anthrax toxin include, pagA, lef, and cya, which encode PA (protective antigen), LF (lethal 
factor), and EF (edema factor), respectively.  The toxin genes are located non-contiguously 
within a pathogenicity island on the 182-kb virulence plasmid pXO1 (84, 103, 113).  
Transcription of the toxin genes is strongly affected by the pXO1-encoded trans-acting 
regulator AtxA.  Each toxin gene contains, at minimum, an atxA-dependent transcription 
start site (36, 76, 87). The capsule biosynthetic operon, capBCADE, located on the 96-kb 
virulence plasmid pXO2 is also positively affected by AtxA (36, 40, 50, 67, 87, 101, 136, 
165, 166).  Transcription of the cap operon involves crosstalk between the two virulence 
plasmids.  In a genetically complete strain containing pXO1 and pXO2, AtxA directs 
transcription of the cap operon via two pXO2-encoded regulators AcpA and AcpB.  The 
acpA gene and cap operon contain atxA-dependent transcription start sites while acpB can 
be transcribed from its own promoter or via transcriptional read-through of the cap operon.  
Co-transcription of acpB with capBCADE results in a positive feedback loop for cap operon 
transcription (41).      
 Expression of the anthrax toxin and capsule genes, and many other atxA-regulated 
genes, is enhanced when cells are cultured in 5% CO2 with media containing 0.8% 
dissolved bicarbonate (9, 18, 28, 33, 36, 50, 75, 77, 87, 101, 137).  The CO2/bicarbonate 
signal is considered physiologically significant for pathogenesis.  However, the molecular 
mechanism by which AtxA and CO2/bicarbonate control the toxin and capsule genes is 
unknown.  AtxA is a 55.6-kDa basic protein with putative helix-turn-helix and winged-helix 
motifs near the amino-terminus, but no specific DNA binding has been demonstrated for 
this protein. Common cis-acting regions of atxA-dependent promoters have not been 
identified.  Nucleotide sequence similarities in promoter regions are not apparent; therefore, 
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it has been suggested that DNA curvature plays a role in AtxA regulation of its target toxin 
and capsule regulator genes (69).   
  In addition to the plasmid-encoded regulators, the chromosome-encoded 
transcription factors AbrB, CcpA, and CodY indirectly affect toxin gene expression by 
controlling atxA at the transcriptional and post-translational level.  The effect of AbrB and 
CcpA on capsule production has not been assessed, but deletion of codY has been 
reported to have no effect on capsule production (31).  The carbon catabolite protein CcpA 
and the pleiotropic regulator CodY both sense the nutritional status within a cell to activate 
or repress their target genes (71, 124, 135, 170).  A ccpA-null mutant exhibits a decrease in 
atxA transcription and produces little to no anthrax toxin (32).  Deletion of codY results in 
decreased toxin production due to decreased AtxA protein levels (168).  The mechanisms 
by which CcpA controls atxA transcription and CodY controls AtxA protein levels are 
unknown.  The transition state regulator AbrB is the only identified trans-acting factor that 
specifically binds the atxA promoter (151).  An abrB-null mutant shows early and increased 
transcription of the anthrax toxin genes (131).   
 AbrB is a pleiotropic DNA-binding regulator that represses post-exponential phase 
genes during logarithmic growth (121, 152, 154, 156).  One of the direct targets of AbrB is 
sigH, a gene encoding an alternative sigma factor that directs the transcription of genes 
associated with the transition into stationary phase of growth (148).  SigH is required during 
the early stages of sporulation to directly promote transcription of several crucial sporulation 
genes (19, 43).  Most importantly, SigH (with core RNA polymerase [RNAP]) activates 
transcription of spo0A, the master response regulator of sporulation (122).  AbrB, Spo0A, 
and SigH are all part of a feedback mechanism that ultimately controls expression of each 
other in addition to multiple other genes.  In B. subtilis, SigH-RNAP directs transcription of 
spo0A, phosphorylated Spo0A represses abrB, and AbrB represses sigH (54, 66, 122, 147, 
148, 151).    
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 In B. anthracis, AbrB, Spo0A, and SigH appear to be part of a similar feedback loop 
regulating the expression of each other, but in addition, control atxA expression.  Multiple 
studies have revealed effects of  AbrB, Spo0A, and SigH on atxA transcription using 
different B. anthracis strains and the heterologous host B. subtilis (14, 68, 131, 151).  The 
results of these studies indicate that AbrB binds to specific sequences in the atxA promoter 
region to repress atxA transcription.  Spo0A positively affects atxA via control of abrB 
expression.  SigH control of atxA occurs via its positive effect on spo0A, and in one strain, 
sigH positively regulates atxA expression in a spo0A- and abrB-independent manner (14, 
68, 151). 
 In this study, I sought to investigate the physiological relevance of atxA regulators in 
B. anthracis disease progression by examining the impact AbrB, Spo0A, and SigH have on 
AtxA, anthrax toxin, and capsule production.  Using a genetically incomplete strain of B. 
anthracis (ANR-1 [pXO1+, pXO2-]), I demonstrate that AtxA and anthrax toxin production 
supports the previously established AbrB/Spo0A/SigH model of atxA regulation.  However, 
AtxA and anthrax toxin production are largely different in a genetically complete B. 
anthracis strain (Ames [pXO1+, pXO2+]) mutated for the developmental regulators because 
of factors on pXO2.  Capsule production is modestly affected by deletion of the 
developmental regulators.  Finally, I show that an abrB-null mutant, in the genetically 
incomplete ANR-1 strain background, is more virulent than the parent and a strain 
overexpressing AtxA (ANR-1 atxA-up mutant).   
  
 
 
 
 
 
 92 
5.2. Results 
 
5.2.1. The developmental regulator AbrB negatively controls atxA transcription 
 There is conflicting evidence regarding the impact of the developmental regulators 
AbrB, Spo0A, and SigH on atxA transcription.  Different B. anthracis Sterne-like (pXO1+, 
pXO2-) strain backgrounds in addition to the heterologous host B. subtilis were used in 
previous investigations assessing atxA expression in developmental regulator mutants.  In 
an attempt to clarify the effects of AbrB, SigH, and Spo0A on atxA transcription, I examined 
atxA promoter activity in the ANR-1 (pXO1+, pXO2-) strain of B. anthracis.  ANR-1 is a 
pXO2-cured toxigenic, noncapsulated variant of the genetically complete, clinical isolate 
Ames (pXO1+, pXO2+) strain and is therefore considered physiologically relevant (172).  
atxA promoter activity was monitored during early exponential (2h), transition (4h), and 
stationary (7h) phases of growth when cultured in toxin-inducing conditions using β-
galactosidase assays (Fig. 5-1).  The minimal atxA promoter (171-bp, see Fig. 3-1) was 
transcriptionally fused to a promoterless lacZ gene and introduced into the B. anthracis 
ANR-1 parent and isogenic developmental regulator mutants.  The ANR-1 parent strain 
containing the atxA promoter-lacZ fusion (PatxA-lacZ) exhibited a maximum β-
galactosidase activity of 72 Miller Units (MU).  Single deletion of either sigH or spo0A and a 
double sigH/spo0A mutant resulted in parent levels of β-galactosidase activity at the 
transition phase of growth (4h; 82 MU, 81 MU, and 78 MU, respectively) suggesting SigH 
and Spo0A have no effect on atxA transcription.  Deletion of abrB resulted in an increase in 
β-galactosidase activity to 244 MU, consistent with AbrB repression of atxA.  Similarly, a 
double abrB/spo0A-null mutant exhibited 216 MU of β-galactosidase activity.  Taken 
together, these data suggest that AbrB represses atxA transcription while SigH and Spo0A 
do not affect atxA expression.   
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Figure 5-1.  β-galactosidase activities of PatxA-lacZ fusions in parent and isogenic 
developmental regulator mutant strains.  Samples were obtained from cultures grown in 
toxin-inducing conditions during early exponential (2h), transition (4h), and stationary (7h) 
phase of growth.  The PatxA-lacZ low copy number plasmid was introduced into parent 
(ANR-1; pink), ∆abrB (UT384; yellow), ∆sigH (UT399; teal), ∆spo0A (UT400, purple), 
∆spo0A/abrB (UT401; maroon), ∆spo0A/sigH (UT402; green), and an empty vector control 
strain (ANR-1 (pHT304-18z); blue).  These data are averaged from three independent 
cultures. 
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5.2.2. Factors on pXO2 impact AtxA expression  
 AtxA protein levels were examined in the ANR-1 parent and isogenic developmental 
regulator mutants to determine if the protein levels reflected atxA promoter activity (Fig. 5-
2A).  I also determined the impact deletion of the developmental regulators had on the 
anthrax toxin proteins PA, LF, and EF (Fig. 5-2B).  There was a 2.8-fold increase in AtxA 
protein levels in the abrB-null mutant with a corresponding 2.1- to 6.9-fold increase in all 
three anthrax toxin proteins.  These results support the model in which AbrB represses atxA 
transcription.  The spo0A/abrB-null strain exhibited a subtle increase in AtxA protein levels 
with a corresponding 1.7- to 3-fold increase in the anthrax toxin proteins.  These results 
support the AbrB/Spo0A/SigH model for regulation of atxA transcription. 
 Single or double deletion of sigH and spo0A in ANR-1 resulted in decreased AtxA, 
PA, and LF production.  These results do not correlate with the parent level of β-
galactosidase activity each PatxA-lacZ fusion exhibited in the sigH and spo0A mutant 
derivatives (Fig. 5-1).  The results suggest that lacZ transcripts were stabilized or AtxA was 
regulated post-translationally in the sigH-, spo0A-, and sigH/spo0A-null strain backgrounds.  
EF production was at parent levels or elevated in the sigH- and spo0A-null mutants 
suggesting factors other than AtxA are impacting EF protein levels in the mutant 
backgrounds.  An ANR-1 atxA-null mutant did not express AtxA and produced little to no 
anthrax toxin.  Taken together, these data indicate that AbrB represses atxA transcription 
while SigH and Spo0A positively influence AtxA expression in the ANR-1 strain 
background. 
 I previously determined that factors on pXO2 influence AtxA expression (see section 
4.2.5).  Therefore, I wanted to determine the impact AbrB, Spo0A, and SigH had on AtxA 
and anthrax toxin production in the genetically complete B. anthracis Ames strain and 
isogenic developmental regulator mutants (Fig. 5-3).  There was a 2.8-fold increase in AtxA 
expression in the Ames abrB-null compared to the ANR-1 abrB-null mutant (Fig. 5-3 and  
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Figure 5-2.  Influence of ANR-1 isogenic developmental regulators on AtxA and 
anthrax toxin expression. Production of (A) AtxA and (B) LF, EF, and PA by ANR-1 
parent and mutant strains. Culture samples were obtained from B. anthracis strains grown 
in toxin-inducing conditions during transition phase (4h) of growth. (A) Samples were 
subjected to SDS-PAGE and Western blot analysis using rabbit α-AtxA antibody raised 
against B. anthracis AtxA or mouse α-RNA Pol β antibody raised against E. coli RNA Pol β. 
(B) Samples were subjected to Slot blot Western analysis using rabbit α-LF, rabbit α-EF, 
and goat α-PA antibodies raised against B. anthracis proteins.  Quantified protein levels 
normalized to load control and parent strain.  These data are representative of three 
separate experiments.  
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Figure 5-3.  Influence of Ames isogenic developmental regulators on AtxA and 
anthrax toxin expression. Production of (A) AtxA and (B) LF, EF, and PA by Ames parent 
and mutant strains. Culture samples were obtained from B. anthracis strains grown in toxin-
inducing conditions during transition phase (4h) of growth. (A) Samples were subjected to 
SDS-PAGE and Western blot analysis using rabbit α-AtxA antibody raised against B. 
anthracis AtxA or mouse α-RNA Pol β antibody raised against E. coli RNA Pol β. (B) 
Samples were subjected to Slot blot Western analysis using rabbit α-LF, rabbit α-EF, and 
goat α-PA antibodies raised against B. anthracis proteins. Quantified protein levels 
normalized to load control and parent strain.  These data are representative of three 
separate experiments. 
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Fig. 5-2).  AtxA expression increased approximately 8-fold in the Ames abrB-null mutant 
versus parent which resulted in a 4.6-fold increase in PA expression.  Similarly, the Ames 
spo0A/abrB-null mutant exhibited an approximate 5-fold increase in AtxA compared to 
parent.  This resulted in a 3.7-fold increase in PA production.  LF and EF production were 
unaffected in the abrB- and spo0A/abrB-null mutants possibly due to misregulation of 
secreted proteases that affect anthrax toxin stability (120).  These secreted proteases 
specifically target the anthrax toxin proteins for degradation and are indirectly controlled by 
AbrB and Spo0A (7, 120, 121, 134). 
 Single or double deletion of sigH and spo0A in Ames resulted in AtxA protein levels 
similar to, or modestly increased, compared to parent.  In agreement with the small 
changes in AtxA levels, there was little to no change in anthrax toxin production in the 
Ames sigH- and spo0A-null mutants.  Anthrax toxin production did increase 1.6- to 2.7-fold 
in the spo0A/sigH-null mutant; however, this strain exhibited a growth defect that resulted in 
cell lysis over time (Fig. 5-4), impacting accurate determination of intracellular versus 
secreted protein levels.  In total, these results are opposite of the decreased AtxA protein 
levels observed in the ANR-1 sigH and spo0A mutant derivatives suggesting interplay 
between factors on pXO2.    Most surprisingly, an Ames atxA-null mutant did not express 
AtxA, but produced PA, LF, and EF at levels comparable to the parent strain, suggesting 
factors on pXO2 also control the anthrax toxins independent of atxA.  Taken together, AtxA 
and anthrax toxin production in the Ames developmental regulator mutants was largely 
different than AtxA protein levels in the ANR-1 developmental regulator mutant derivatives 
indicating that factors on pXO2 impact both AtxA and anthrax toxin expression.   
 Multiple techniques were used to create a double sigH/abrB-null mutant in the ANR-
1 and Ames strain backgrounds; however, the double deletion mutant could not be created 
due to unknown reasons.  To this end, I could not clear up confusion regarding whether 
SigH controls AtxA expression in an AbrB-dependent or -independent manner.  Variable  
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Figure 5-4.  Growth curve of Ames parent and developmental regulator mutants.  B. 
anthracis strains were cultured in toxin conditions (CACO3 + 5% CO2) and the optical 
density at 600 nm (OD600) was measured hourly.  These data are representative of three 
independent cultures. 
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phenotypes were often observed in the Ames sigH-null mutant concerning AtxA and 
anthrax toxin protein levels.  In addition, creation of the Ames and ANR-1 sigH-null mutants 
was difficult and the ANR-1 sigH-null mutant sporulation defect could not be complemented 
(data not shown).  In combination, these results suggest that SigH is a critical sigma factor 
and pleiotropic regulator in B. anthracis.     
 
5.2.3. SigH positively controls atxA transcription 
 The impact of the alternative sigma factor SigH on atxA transcription is highly 
controversial.  Hadjifrangiskou et al. (68) demonstrated SigH positively controlled atxA 
transcription in an AbrB-independent manner whereas other groups reported that SigH 
control of atxA transcription was AbrB-dependent (14, 151).  In all previous reports, different 
Bacillus species strains were used including genetically incomplete Sterne-like (pXO1+, 
pXO2-) B. anthracis strains and a B. subtilis heterologous host strain.  Therefore, I wanted 
to determine if SigH controlled atxA transcription in the genetically complete B. anthracis 
Ames strain.  atxA transcript levels were determined in the Ames parent, sigH-null, and 
sigH complemented strains using RT-qPCR.  The relative transcript levels were normalized 
to the housekeeping gene gyrB.  A sigH-null strain exhibited a 2.2-fold decrease in atxA 
transcripts compared to parent.  When sigH was reintroduced into the sigH-null mutant, 
atxA transcript levels increased to levels slightly higher than parent indicating that SigH 
positively controls atxA transcription (Fig. 5-5).  However, since a double sigH/abrB-null 
mutant could not be created, it is unclear if the observed phenotype is AbrB-dependent or –
independent.  The 2.2-fold decrease in atxA transcripts in the Ames sigH-null mutant did 
not translate to a measurable decrease in AtxA protein levels (Fig. 5-3A).  Nevertheless, 
these results demonstrate that SigH positively controls atxA transcription in a genetically 
complete B. anthracis strain background.   
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Figure 5-5.  atxA transcript levels in parent and sigH mutant strains.  Sample for RT-
qPCR were obtained from B. anthracis parent (Ames, blue), ∆sigH (UTA16; red partial fill), 
and ∆sigH::sigH (UTA17; red) cultured in toxin-inducing conditions during transition (4h) 
phase of growth.  Transcript levels normalized to the housekeeping gene gyrB.  Data are 
averaged from three independent cultures.  Strain creation and RNA manipulation 
performed by Jason Rall, Ph.D.  
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5.2.4. Altered AtxA expression affects capsule production 
 AtxA positively affects transcription of the capsule biosynthetic operon via control of 
the capsule gene regulators acpA and acpB (40, 67, 166, 169). Since the developmental 
regulators control atxA transcription, I decided to determine if altered AtxA expression 
would impact capsule production.  The production of capsule was assessed using India ink 
exclusion assays in which the capsule appears as a halo surrounding the bacilli.  All strains 
produced capsule; however, the amount and uniformity of the capsule varied among the 
strain backgrounds (Fig. 5-6).  Capsule synthesis by the atxA-null strain was delayed and 
reduced compared to the parent strain.  The single abrB- and sigH-null mutants produced 
capsule similar to parent while mutation of spo0A resulted in irregular production of 
capsule.  Some bacilli within a chain of a spo0A-null mutant produced parent levels of 
capsule while other bacilli within the same chain had reduced capsule production.  The 
abrB/spo0A- and spo0A/sigH-null mutants exhibited mixed phenotypes where some chains 
produced parent levels of capsule and other chains were more variable for capsule 
production.  In addition, a single or double sigH-null mutant produced shorter and smaller 
cells that were always capsulated.  Together, these results indicate that altered AtxA 
expression impacted the uniform production of capsule.     
 
5.2.5. An abrB-null mutant is more virulent than parent 
 Given the increased toxin production by the abrB-null and atxA-up mutants, I 
considered whether the mutants would display increased virulence in a murine model in 
which toxin plays an important role in pathogenesis.  Vegetative cells obtained from B. 
anthracis ANR-1 parent and isogenic atxA-null, abrB-null, and atxA-up (see section 3.2.6) 
strains were injected via the tail vein into 6- to 8-week-old female A/J mice.  Mice were 
monitored for signs of disease for 7 days post-infection.  A/J mice are complement deficient 
therefore more susceptible to anthrax toxin and are often used when studying the affects of  
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Figure 5-6.  Capsule production is modestly affected by mutation of the 
developmental regulators AbrB, Spo0A, and SigH. B. anthracis Ames parent and mutant 
strains were cultured in toxin-inducing conditions and capsule was visualized during 
stationary (7h) phase of growth using India ink exclusion assays.  Micrograph inserts depict 
representative altered capsule phenotypes of each respective mutant strain.  These data 
are representative of three separate experiments. 
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Figure 5-7. Elevated AtxA expression is not sufficient for increased virulence. 
Survival curves of mice infected intravenously (i.v.) with vegetative ANR-1-derived B. 
anthracis strains. A/J mice were injected i.v. with 1.5x102 CFU of parent (n=6), 1.9x102 CFU 
of atxA-up (n=6), 0.9x102 CFU of ∆abrB (n=6), and 1.5x103 CFU of ∆atxA (n=3) vegetative 
cells.  An ∆atxA mutant is avirulent. Both the parent and atxA-up mutant had similar 
virulence with no significant difference in MTD.  The ∆abrB mutant had a MTD of 84.5 h.  
Injections performed by Malik Raynor and Prabhat Dwivedi, Ph.D.  
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B. anthracis toxin on virulence (173).  There was no significant difference in the mean time 
to death (MTD) of mice infected with 102 CFU of the parent or an atxA-up mutant.  Infection 
with the parent and atxA-up mutant strains resulted in a MTD of approximately 113 and 119 
h, respectively.  The ANR-1 abrB-null mutant was more virulent than parent and the atxA-
up strain with a MTD of 84.5 h.  An atxA-null mutant was avirulent (Fig. 5-7). 
 The atxA-up mutant produced more AtxA, PA, LF, and EF than both parent and the 
abrB-null mutant (Fig 3-8 and Fig. 5-2A); however, the atxA-up mutant was not more 
virulent.  It is possible that the phenotype of the atxA-up mutant in batch culture is not 
mirrored during infection.  These results indicate that increased production of AtxA and 
anthrax toxin expression in batch culture does not necessarily translate to an increase in 
virulence in a murine model for anthrax disease.  The results also suggest that the 
increased virulence of an abrB-null mutant is not attributed to increased AtxA and anthrax 
toxin production.  
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5.3. Discussion 
 The AbrB/Spo0A/SigH model for regulation of atxA transcription was initially 
established using the heterologous host B. subtilis parent and isogenic developmental 
regulator mutants harboring a B. anthracis atxA promoter – lacZ fusion (PatxA-lacZ) (151).  
B. subtilis is the most extensively studied Bacillus species and has been used for several 
years as the model Gram-positive bacterium.  B. anthracis is similar to B. subtilis and 
contains several homologous proteins with similar functions.  B. anthracis is a member of 
the Bacillus cereus group that contains six closely related species, which does not include 
B. subtilis.  It has become apparent based on similar studies regarding the role of AbrB, 
Spo0A, and SigH on atxA expression performed in B. anthracis that B. subtilis is not the 
best model system to examine B. anthracis gene regulation. 
 In B. subtilis, abrB negatively controls atxA expression while spo0A and sigH both 
positively affect atxA expression in an abrB-dependent manner (151).  There are conflicting 
reports as to whether SigH controls atxA transcription independent of AbrB in B. anthracis.  
Hadjifrangiskou et al. (68) demonstrated that atxA expression requires sigH and that SigH 
positively controls atxA transcription in an abrB-independent manner.  The atxA promoter 
does not contain a consensus sequence for SigH; therefore, it is suggested that SigH 
indirectly activates atxA transcription.  Alternatively, it has been proposed that the B. 
anthracis and B. subtilis SigH proteins are functionally different and that the B. anthracis 
SigH recognizes a non-canonical consensus sequence.  In contrast, Bongiorni et al. (14) 
showed that atxA transcription does not require SigH and that atxA promoter activity is 
unaffected by deletion of sigH.  The lack of agreement between results obtained in B. 
anthracis and the use of different B. anthracis strain backgrounds suggests that the SigH 
phenotype is strain-dependent. 
 The activity of AbrB, Spo0A, and SigH is growth phase dependent; therefore, growth 
condition impacts their function.  Spo0A is the master response regulator for the initiation of 
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sporulation and is activated when conditions are conducive for sporulation (142).  Strauch 
et al. (151) examined PatxA-lacZ expression in B. subtilis cells cultured in conditions 
conducive for sporulation (Schaeffer’s sporulation medium) when Spo0A can actively 
repress abrB.  Therefore, deletion of B. subtilis sigH reduced transcription of spo0A 
enabling increased repression of PatxA-lacZ by AbrB.  This sigH-null phenotype was not 
apparent when Bongiorni et al. (14) determined PatxA-lacZ expression levels in B. 
anthracis likely because the culture conditions used were not conducive for sporulation.  
Instead, Bongiorni et al. (14) cultured B. anthracis in either LB/air or R medium containing 
0.8% dissolved bicarbonate and an atmosphere of 5% CO2.  The later growth condition is 
physiologically significant for a bacterial pathogen and is thought to model the host 
environment.  Hadjifrangiskou et al. (68) also used growth conditions thought to model 
growth within a host (CACO3 + 5% CO2); however, atxA expression required sigH.  The 
slight variation in media composition and/or the difference in B. anthracis strain could 
explain the discrepancy with the Bongiorni et al. (14) results regarding SigH control of atxA 
transcription.  
 Here I showed that the established AbrB/Spo0A/SigH model for atxA regulation did 
not take into account factors on pXO2 that could control AtxA expression.  Single and 
double deletions of abrB, spo0A, and sigH resulted in different AtxA expression levels 
depending on B. anthracis strain background.  abrB had a more pronounced negative 
impact on AtxA production in the genetically complete Ames versus genetically incomplete 
ANR-1 strain background.  sigH and spo0A appeared to be strong positive regulators of 
AtxA production in ANR-1 whereas they had little to no effect on AtxA expression in Ames.  
The only difference between ANR-1 and Ames is the presence of pXO2.  I previously 
showed that deletion of pXO2-61 resulted in decreased AtxA expression suggesting that 
pXO2-61 positively impacts atxA by an unknown mechanism (see section 4.2.5).  The data 
I have presented herein and the results I showed in Chapter 4 indicate that factors on pXO2 
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impact AtxA expression.  It is becoming increasingly apparent that future studies 
determining the molecular mechanisms controlling atxA expression must be employed in 
genetically complete B. anthracis strain backgrounds.   
 In this chapter, I have also demonstrated that anthrax toxin production does not 
directly correlate with AtxA expression levels in the genetically complete Ames isogenic 
developmental regulator mutants.  Pflughoeft et al. (120) reported previously that one of the 
most abundant proteins in the secretome of B. anthracis is the zinc metalloprotease InhA1 
(immune inhibitor A1) which targets the anthrax toxin proteins (Fig. 5-8).  An inhA1-null 
mutant displays increased and extended production of PA, LF, and EF (120).  InhA1 levels 
are controlled by the transition state regulator SinR, and the SinR antagonist SinI.  SinR 
represses inhA1 transcription during exponential growth.  As a culture transitions into 
stationary phase, SinI protein levels accumulate due to relieved repression by AbrB (7, 121, 
134).  This results in SinI interaction with SinR and relieved repression of inhA1.  Once 
expressed, InhA1 is post-translationally regulated by the protease camelysin.  In a 
genetically incomplete strain of B. anthracis, there is an inverse relationship between 
camelysin and InhA1 production, as camelysin levels increase InhA1 levels decrease (120).  
The regulation of calY and inhA1 has not been extensively studied in a genetically complete 
B. anthracis strain.  Therefore, the impact deletion of the developmental regulators abrB, 
spo0A, and sigH ultimately has on camleysin and InhA1 expression levels is unknown. 
Furthermore, the unexpected increases and decreases in secreted PA, LF, and EF could 
be a result of indirect camelysin and InhA1 misregulation by AbrB.  
 Finally, I showed that an ANR-1 abrB-null mutant was more virulent than parent and 
an ANR-1 atxA-up mutant.  Both the abrB-null and atxA-up mutants produced elevated 
levels of AtxA and anthrax toxin when cultured in vitro.  The impact of altered AtxA levels on 
virulence has not been examined previously.  Rather, previous investigations have focused  
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Figure 5-8.  Model for post-translational regulation of the anthrax toxins proteins by 
secreted proteases when cultured in toxin-inducing conditions.  The structural genes 
for anthrax toxin, cya, pagA, and lef, are positively controlled by AtxA.  The expression level 
of AtxA is controlled by the developmental regulators AbrB, Spo0A, and SigH which in turn 
regulate each others expression in addition to multiple other genes.  AbrB controls SinI/R 
which regulate calY (camelysin) and inhA1 (InhA1) production.  In the culture supernatant, 
camelysin and InhA1 are capable of degrading the anthrax toxins.  Solid shapes represent 
active proteins while spotted shapes signify cleaved (inactive) proteins.  
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on the virulence of B. anthracis strains defective for AtxA or anthrax toxin production (30-
32, 36, 74, 93, 95, 168).  Overexpression of AtxA and anthrax toxins did not correlate with 
the severity of anthrax disease.  The increased virulence exhibited by the abrB-null mutant 
and lack of enhanced virulence in the atxA-up mutant indicates that AbrB is affecting other 
factors that are influencing pathogenesis.  In batch culture, an abrB-null mutant produces 
longer chains of bacilli than parent or an atxA-up mutant (Fig. 5-9).  Glomski et al. (58) have 
reported previously that tail vein injections of B. anthracis ‘long bacteria’ (approximately 
20µm in length) were detected solely in the lungs of mice and resulted in rapid mortality.  
We did not examine the dissemination pattern or histopathology of B. anthracis infected 
mice.  Therefore, it is possible that an abrB-null mutant leads to obstructive morphologies 
within the host.  Future studies examining the histopathology of an abrB-null infected 
mouse would be valuable for understanding the mechanism by which an abrB-null mutant 
enhances B. anthracis virulence.   
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Figure 5-9.  Extended chaining phenotype of an ∆abrB mutant.  Phase contrast 
microscopy showing B. anthracis parent and ∆abrB strains in toxin-inducing batch culture 
conditions (CACO3 + 5% CO2).  These data are representative micrographs.  Microscopy 
performed by Prabhat Dwivedi, Ph.D. 
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 B. anthracis is an endemic soil bacterium that has adapted to two different lifestyles: 
a nonpathogenic lifestyle of survival and saprophytic growth in the soil, and a pathogenic 
lifestyle of inhabiting mammalian hosts.  The developmental characteristics of B. anthracis 
enable the bacterium to exist as an environmentally resistant spore in the soil, and a 
vegetative cell that produces essential virulence factors within the host.  B. anthracis 
senses and responds to environment-specific signals to facilitate adaptation and growth in 
different conditions.  These signals elicit responses such as production of the virulence 
factors, anthrax toxin and capsule, and development into dormant spores.  My work is the 
first to demonstrate that in batch culture conditions there is an inverse relationship between 
B. anthracis toxin production and sporulation.  In addition, my studies are the first to reveal 
that cellular development, like toxin production, is affected by the regulatory protein AtxA.   
 Using different batch culture conditions, I modeled physiologically relevant 
conditions encountered by B. anthracis during infection (toxin-inducing conditions), and 
environmental conditions in the soil (sporulation conditions).  My data indicate that in 
specific culture conditions, there is an AtxA-associated inverse relationship between toxin 
production and sporulation.  In conditions that favor sporulation, B. anthracis sporulates but 
produces little to no AtxA and LF.  In conditions that are not conducive for sporulation, B. 
anthracis does not sporulate but produces AtxA and LF (Fig. 4-1).  Furthermore, 
overexpression of AtxA results in a marked sporulation defect (Fig. 4-2) which in 
combination with the above data implicates the master virulence regulator AtxA in B. 
anthracis spore development.  Moreover, the inverse expression of AtxA in toxin-inducing 
versus sporulation conditions strongly suggests that atxA is differentially regulated by trans-
acting factors in each culture condition.   
 The only trans-acting factor shown to directly bind to the atxA promoter repressing 
transcription is the transition state regulator AbrB.  Here I demonstrate that an additional 
trans-acting factor(s) other than AbrB binds specifically to the atxA promoter region to 
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negatively impact atxA expression (Fig. 3-3 and Fig. 3-4B).  In this discussion, I refer to the 
unidentified trans-acting factor(s) that controls atxA transcription as the “atxA repressor 
protein(s)”.   Based on my work, I consider a model in which B. anthracis requires AbrB and 
the atxA repressor protein(s) to differentially regulate atxA transcription in two distinct 
environments.  I propose that AbrB controls atxA in toxin-inducing conditions whereas the 
atxA repressor protein(s) predominately regulates atxA transcription in sporulation 
conditions.  Since the transcriptional regulation of atxA is complex and involves multiple 
signals and trans-acting factors that function in growth condition- and strain-dependent 
manners, the discussion is organized in different sections.  These sections explain atxA 
regulation in each culture condition, the potential impact of atxA repressor protein(s) binding 
on AbrB interaction with the atxA promoter region, and the affect of AtxA overexpression on 
virulence.  There is partial overlap between regulators in each culture condition; therefore, 
some repetition occurs in each section.   
 
Regulation of atxA in toxin-inducing conditions (CACO3 + 5% CO2) 
 The most critical factor controlling atxA expression in toxin-inducing conditions is the 
transition-state regulator AbrB.  AbrB represses atxA transcription by binding to a 43-bp 
region located upstream of the P1 transcription start site (151) (Fig. 6-1A).  atxA transcripts 
are relatively low during exponential phase indicating that AbrB does not completely 
repress transcription.  As the culture approaches stationary phase of growth, AbrB protein 
levels decrease (110) and atxA transcripts increase (131).  Extensive studies in the 
archetype Bacillus species, B. subtilis, have revealed that AbrB is a DNA binding protein 
that controls several post-exponential phase genes associated with metabolic and 
physiological processes (121, 150).  One of the direct targets of AbrB is the alternative 
sigma factor gene sigH.  AbrB, SigH, and the master response regulator Spo0A are all part 
of a feedback loop, as depicted in Fig. 6-1B.  Transcription of sigH is repressed by AbrB, 
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Figure 6-1. Model for regulation of atxA gene expression in toxin-inducing and 
sporulation conditions.  The developmental regulators AbrB, Spo0A, and SigH regulate 
atxA transcription in a condition-dependent manner.  In toxin-inducing conditions, AbrB 
binds to a region upstream of P1 to actively represses atxA expression (A), whereas in 
sporulation conditions, AbrB plays a minor role in control of atxA (G).  Data suggest that 
factors on pXO2 control AbrB protein levels (C).  In toxin-inducing conditions, atxA 
positively controls pXO2-61 transcription (E).  In sporulation conditions, the atxA repressor 
protein (referred to as ‘Repressor’ in the model) interacts with a palindromic sequence 
located downstream of P1 (H).  Activity of the repressor is down-regulated by pXO2-61 (D 
and I).  Additional signals impacting atxA expression are carbohydrate availability, 
temperature, and redox potential (F and J).  Thick lines denote important trans-acting 
factors or signals controlling atxA expression in the given culture condition.  Thin lines 
denote minimal impact.  Hashed lines indicate suggested function. Curved lines/arrows 
represent indirect affects on atxA transcription.      
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SigH (with core RNAP) transcribes spo0A, and phosphorylated Spo0A represses abrB.  B. 
anthracis contains orthologues of the developmental regulators.  Therefore, it is inferred 
that the developmental regulators perform similar functions in B. anthracis.  In large part, 
the expression of AbrB and SigH is controlled by the threshold level of 
active/phosphorylated Spo0A.  Spo0A is phosphorylated by components of the sporulation 
phosphorelay that are activated in response to nutrient limitation.  I propose that toxin-
inducing conditions are not optimal for Spo0A phosphorylation; however, as nutrients are 
depleted during the transition into stationary phase of growth low levels of Spo0A~P 
repress abrB.  Fujita et al. (53) showed that in B. subtilis Spo0A~P binds to the abrB 
promoter with relatively high affinity.  Therefore, abrB repression by Spo0A~P requires a 
low threshold level of protein.  In B. anthracis, this repression of abrB by Spo0A~P results 
in increased atxA transcription.       
 My work demonstrates that the AbrB/Spo0A/SigH model for regulation of atxA is 
strain-dependent.  This model was initially determined based on results obtained from B. 
subtilis and B. anthracis Sterne-like (pXO1+, pXO2-) strains harboring transcriptional atxA 
promoter–lacZ fusions (14, 68, 131, 151).  I examined atxA transcription in the Sterne-like 
strain ANR-1, which is more physiologically relevant than the previously used Sterne-like 
strains.  ANR-1 is a pXO2-cured toxigenic, noncapsulated variant of the clinical isolate 
Ames that has a documented genomic background and is less of a lab strain.  Using the 
ANR-1 parent and developmental regulator mutants, I determined variations exist in the 
AbrB/Spo0A/SigH model for regulation of atxA transcription.  First, I observed a greater 
increase (3.4-fold) in atxA promoter activity than AtxA protein levels (2.8-fold) in the abrB-
null mutant.  Previously, AtxA protein levels were not quantified in an ∆abrB mutant.  
Instead, it was assumed that AtxA protein levels reflected atxA promoter activity which 
increased approximately 4-fold among the different strain backgrounds (68, 131, 151).  
Nonetheless, anthrax toxin protein levels were elevated 2.1- to 6.9-fold in the ∆abrB mutant 
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compared to parent.  Second, the ∆spo0A/abrB mutant exhibited a 3-fold increase in atxA 
promoter activity; however, there was a subtle 1.7-fold increase in AtxA protein levels which 
translated to a 1.7- to 3-fold increase in the anthrax toxin proteins. 
 After examination of B. anthracis mutant phenotypes in a genetically incomplete 
(pXO1+, pXO2-) strain background, it is common laboratory practice to determine if the 
given phenotypes ‘hold true’ in a genetically complete (pXO1+, pXO2+) strain background.  
Using the Ames strain that harbors pXO1 and pXO2, my results demonstrate that AbrB is 
the only developmental regulator to significantly affect atxA expression.  Deletion of abrB 
resulted in a 7.9-fold increase in AtxA protein levels, and the ∆spo0A/abrB mutant exhibited 
a 5.3-fold increase in expression of AtxA.  The level of AtxA modestly increased or was 
unchanged in the single and double sigH and spo0A mutants.  This result does not support 
the AbrB/Spo0A/SigH model of atxA regulation since deletion of sigH or spo0A should 
result in elevated AbrB and constant repression of atxA.  In total, these results would 
suggest that additional factors other than SigH and Spo0A negatively control AbrB in a 
genetically complete strain background.  I propose a model by which factors present on 
pXO2 negatively control AbrB in a sigH- and spo0A-independent manner (Fig. 6-1C).  To 
test this model, a library of pXO2 genes could be introduced into a pXO2-cured B. anthracis 
strain harboring an abrB reporter construct to screen for abrB phenotypes.  Transcriptional 
and translational abrB reporter constructs could be created to identify the level at which 
abrB is regulated by pXO2 factors.  In addition, pXO2 could be analyzed for annotated 
regulatory genes that could serve as targets for directed gene deletion and examination into 
what role, if any, there is on AbrB expression.  Interestingly, anthrax toxin production in the 
various Ames isogenic developmental mutants did not directly correlate with the level of 
AtxA which also suggests that factors on pXO2 are indirectly controlling B. anthracis 
anthrax toxin-specific proteases via control of AbrB (for details see section 5.3 and Fig. 5-
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7).  In total, these results would imply that factors on pXO2 are indirectly controlling both 
atxA expression and anthrax toxin levels.   
 Another line of evidence suggesting that factors on pXO2 regulate atxA expression 
is that mutation of the atxA repressor protein(s) binding site results in overexpression of 
AtxA in a genetically incomplete (ANR-1) and not genetically complete (Ames) strain 
background.  Furthermore, AtxA protein levels decreased 4-fold in a ∆pXO2-61 mutant and 
were restored to parent levels in the double ∆pXO2-61/atxA-up mutant.  Transcriptional 
profiling experiments showed that atxA positively affects pXO2-61 transcription (54-fold), 
and overexpression of pXO2-61 was shown to negatively impact sporulation (18, 174).  The 
affect of pXO2-61 overexpression on sporulation will be detailed in the next section.  Here I 
will focus on how the lack of pXO2-61 negatively affects AtxA protein levels.  I propose that 
pXO2-61 somehow represses or inhibits the activity of the atxA repressor protein(s) (Fig. 6-
1D).  Future experiments assessing the mechanism by which pXO2-61 controls AtxA 
expression might reveal a direct affect on the atxA repressor protein(s).  Crude cellular 
extract obtained from an ANR-1 B. anthracis strain overexpressing pXO2-61 could be used 
in EMSAs with a radioactive PatxA probe.  A diminished DNA mobility shift would infer that 
pXO2-61 is necessary and sufficient for indirectly regulating atxA expression via the atxA 
repressor protein(s).  No change in the DNA mobility shift would suggest that other factors 
on pXO2 are involved in negatively controlling the atxA repressor protein(s).  Overall, these 
results underscore the importance of using a genetically complete strain of B. anthracis to 
investigate atxA regulation. 
 Other factors shown to influence atxA transcription in toxin-inducing conditions are 
temperature and the presence of glucose (carbohydrate availability) (Fig. 6-1F).  In 
concordance with the significance of AtxA for B. anthracis pathogenesis, the optimal 
temperature for atxA transcription is 37°C (35).  In the presence of glucose, atxA 
transcription is stimulated due to indirect activation by the carbon catabolite protein CcpA 
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(32).  The mechanism by which temperature and CcpA positively control atxA transcription 
is not clear.   
 
Regulation of atxA in sporulation conditions (PA-air)  
 The most critical regulator of atxA expression in sporulation conditions is the atxA 
repressor protein(s).  Sequences within a 9-bp palindrome located immediately downstream 
of the atxA P1 transcription start site are critical for atxA repressor protein(s) binding and 
negative regulation of atxA transcription (Fig. 6-1H).  Unlike in toxin-inducing conditions, 
AbrB plays little to no role in the regulation of atxA transcription in sporulation conditions.  
atxA transcript levels decrease approximately 3- to 4-fold in sporulation conditions and are 
unaffected by the deletion of abrB (Hadjifrangiskou, M. and J.L. Dale unpublished).  This 
correlates with the fact that abrB transcripts are low in sporulation conditions as a result of 
increased threshold levels of Spo0A~P binding to the abrB promoter region repressing 
transcription (Fig. 6-1G).   
 One of the most intriguing phenotypes associated with mutation of sequences within 
the 9-bp palindrome repressor binding site, was the pXO2-dependent marked decrease in 
sporulation that resulted due to overexpression of AtxA.  The sporulation defect was 
suppressed by deletion of pXO2-61.  The pXO2-61 protein is homologous to the sensor 
domain of sporulation sensor histidine kinases which are key components of the sporulation 
phosphorelay.  White et al. (174) demonstrated that overexpression of this highly AtxA-
regulated gene led to a sporulation defect.  I took those results one step further and 
showed that misregulation of atxA resulted in the physiologically significant developmental 
defect due to elevated pXO2-61 transcription.  Since the typical transcript level of pXO2-61 
is low in sporulation conditions, I did not observe any differences in AtxA protein levels in a 
∆pXO2-61 mutant compared to parent.  This suggests that pXO2-61 has a minimal impact 
on the atxA repressor protein(s) in sporulation conditions unlike the observed impact pXO2-
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61 had on AtxA levels in toxin-inducing conditions (Fig. 6-1I).  Previous publications have 
alluded to AtxA or factors on pXO1 having an impact on B. anthracis development based on 
indirect evidence (75, 102, 158).  To my knowledge, my data is the first work directly 
demonstrating that AtxA modulates spore development.     
 The mechanism by which overexpression of pXO2-61 negatively impacts 
sporulation is not clear.  White et al. (174) determined that the marked sporulation defect 
observed in a pXO2-61 overexpression mutant was BA2291-dependent.  BA2291 is one of 
the major sporulation sensor histidine kinases that initiates the sporulation phosphorelay in 
B. anthracis (21).  It has been proposed that pXO2-61 is capable of titrating away an 
activating signal from BA2291 that results in BA2291 conversion to a phosphatase of 
Spo0F, a key sporulation phosphorelay transducer protein.  Recently, Eswaramoorthy et al. 
(48) demonstrated that the major sporulation sensor histidine kinase in B. subtilis, KinA, is 
activated by multimerization and not detection of a sporulation-specific signal.  There are no 
orthologues of BA2291 in B. subtilis; however, it would be interesting to determine if one of 
the B. anthracis major sporulation sensor histidine kinases (i.e. BA2291) is capable of 
forming homo- or hetero-complexes.  Futhermore, affinity purification pull-down 
experiments using pXO2-61 could determine if and/or what factors associate with the 
protein to inhibit sporulation when overproduced.  
 Other factors affecting atxA transcription in sporulation conditions include redox 
potential and temperature.  A relationship between redox potential and atxA expression was 
demonstrated when genes involved in cytochrome c maturation were deleted.  Deletion of 
two small c-type cytochromes resulted in early and increased transcription of atxA that was 
transient and indirect (175).  Similar to toxin-inducing conditions, atxA transcription is 
optimal at 37°C.  The mechanisms by which the small c-type cytochromes and temperature 
affect atxA transcription remain elusive.     
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The atxA repressor protein(s) and AbrB bind the atxA promoter region independently 
 My data indicate that nucleotides within the palindromic sequence (+14 to +22), 
located downstream of the P1 transcription start site, are required for the atxA repressor 
protein(s) to interact with the atxA promoter region.  The presence of a trans-acting factor 
binding site downstream of a transcription start site is not uncommon.  In both B. subtilis 
and B. anthracis, the abrB promoter contains two tandem ‘0A’ boxes for Spo0A recognition 
located downstream of the transcription start site from sequences +7 to +34, relative to the 
abrB P2 start site (147, 151).  Binding of Spo0A to the abrB promoter negatively regulates 
gene transcription (119, 147, 154).  Another similarity between the atxA and abrB promoter 
regions is the presence of AbrB binding sites upstream of the transcription start sites.  AbrB 
represses atxA transcription by binding to a 43-bp region located 25 to 67 bp upstream of 
the P1 transcription start site (151).  The abrB promoter autoregulates its own expression 
and contains both a high-affinity (-14 to -43) interaction region and contiguous low-affinity (-
44 to approximately -120) binding region for AbrB (154).  Strauch et al. (147) demonstrated 
that the separation between the AbrB and Spo0A binding sites within the abrB promoter 
region resulted in independent binding of each trans-acting factor to its cognate DNA 
sequence.  Even though AbrB binds to its target DNA sequence based on DNA structure 
and curvature, the conformational change caused by Spo0A binding did not alter the 
binding of AbrB.  Based on these results, I propose a model whereby the atxA repressor 
protein(s) binds to the atxA promoter in an abrB-independent manner.  Future 
investigations establishing the epistatic and biochemical relationship between AbrB and the 
atxA repressor protein(s) could determine if the proteins function in a cooperative or 
competitive manner to control atxA expression.  
 The atxA repressor protein(s) must first be identified in order to determine epistatic 
and biochemical relationships with AbrB.  In the course of my studies, I was unable to 
determine the identity of the atxA repressor protein(s).  However, in my attempts to purify 
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and identify the atxA repressor protein(s) from B. anthracis crude cellular extract I obtained 
knowledge regarding the general characteristics of the atxA repressor protein(s).  Using 
biochemical methods of purification, I determined that the atxA repressor protein(s) could 
stably bind a cation exchange column and elute off the column using 496-696 mM NaCl.  
The methods used for partial purification of the atxA repressor protein(s) revealed that the 
pI of the protein(s) is ≥5.6.  In addition, the atxA repressor protein(s) was shown to be 
unstable; freeze/thaw cycles resulted in loss of DNA-binding activity.  Based on these 
preliminary results, future work should focus on using biochemical methods of purification 
including the use of a high-resolution cation exchange column and elution gradients within 
the range of 496-696 mM NaCl.  The semi-enriched cellular extract can further be used with 
affinity purification methods and an atxA promoter concatamer containing the minimal 
repressor binding site to “pull-down” and identify the atxA repressor protein(s).  Once 
identified, purified atxA repressor protein(s) could be used in DNase I footprinting 
experiments with AbrB to determine if the binding of one protein affects interaction of the 
other protein for binding to the atxA promoter region.  
 
Impact of increased AtxA expression on virulence 
 An ∆atxA mutant is severely attenuated for virulence in a murine model for anthrax 
disease demonstrating the necessity of atxA for pathogenesis (36) (Fig. 5-6).  Several 
researchers have investigated the impact of decreased atxA and anthrax toxin production 
on virulence (30-32, 36, 74, 93, 95, 168).  However, no one has investigated the 
consequence of increased AtxA and anthrax toxin production on virulence.  For the first 
time, I had the opportunity to determine if elevated AtxA and anthrax toxin production 
affected virulence of B. anthracis in a murine model of anthrax disease.  Surprisingly, my 
results showed that an atxA-up mutant which produces 6.6-fold more AtxA than the parent 
strain did not exhibit enhanced virulence whereas the ∆abrB mutant which produces a 
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modest 1.4-fold increase in AtxA was more virulent.  It is possible that a specific and critical 
level of atxA is required for optimal expression of the toxin genes, or other atxA-regulated 
genes, in vivo.  Overexpression of anthrax toxins does not correlate with the severity of 
disease; therefore, it is also possible that too much toxin production is problematic for 
virulence.  Alternatively, it is possible that there is another abrB-controlled phenotype such 
as cell length that is important for virulence.  An ∆abrB mutant produces extremely long 
chains of bacilli in batch culture (Fig. 5-9).  Glomski et al. (58) have reported previously that 
the size of bacteria in the inoculating culture influences the dissemination of bacteria to the 
lungs and other organs. ‘Long bacteria’ (approximately 20µm in length) were detected 
solely in the lungs of mice and resulted in rapid mortality when injected via the tail vein.  
Future histopathology experiments on mice infected with the ∆abrB mutant could help 
determine if the mutant strain produces ‘long bacteria’ in vivo.  Furthermore, assessing the 
dissemination of an ∆abrB mutant could reveal if an altered dissemination pattern is 
attributed to the virulence phenotype.   
 
Relationships between bacterial development and toxin production in other 
pathogens  
 Links between signals and regulators controlling sporulation and virulence gene 
expression have also been found in other bacterial pathogens.  Another member of the 
Firmicute phylum, Clostridium difficile, is a spore-forming, pathogenic bacterium that causes 
infections ranging from mild diarrhea to fatal pseudomembranous colitis. The spore 
constitutes the etiological form of C. difficile infections and once ingested can germinate 
and colonize the gut where it produces toxins (4, 100).  Hypervirulent strains of C. difficile 
have become an emerging problem in hospitals and the mechanism(s) leading to 
hypervirulence is being investigated by several laboratories.  There are conflicting reports 
regarding a potential relationship between sporulation and virulence in this species.  
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Akerlund et al. (4) reported an inverse correlation between C. difficile toxin yield and 
sporulation.  These results support the author’s hypothesis that toxin production and 
sporulation represent alternative survival strategies for C. difficile in nutrient deplete 
conditions.  In contrast, a recent report by Merrigan et al. (100) demonstrates that 
hypervirulent clinical isolates of C. difficile sporulate earlier and produce more spores than 
non-hypervirulent strains.  These results suggest a relationship exits between sporulation 
and toxin production.  Discrepancies between the two reports could be a result of different 
culturing methods and media.  Nonetheless, further research is required to determine if 
there is a relationship between C. difficile toxin production and development.  
 A more closely related species to B. anthracis, B. thuringiensis, is also a 
developmental pathogen that produces secreted virulence factors. The pathogenic 
properties of B. thuringiensis are in large part attributed to expression of the pleiotropic 
virulence regulator PlcR (see sections 1.4 and 1.5).  The plcR gene is repressed by Spo0A, 
the master response regulator for sporulation initiation, suggesting a relationship between 
development and virulence factor synthesis.  Nevertheless, overexpression of plcR in B. 
thuringiensis has no negative affect on sporulation (102).  Interestingly, B. anthracis does 
not possess a functional plcR gene, but introduction and overexpression of the B. 
thuringiensis plcR gene results in a marked sporulation defect.  The B. anthracis sporulation 
defect is rescued upon deletion of atxA (102).  These results indicate that plcR is negatively 
controlling sporulation in an atxA-dependent manner and that atxA is the important factor 
contributing to the developmental defect.  The exact mechanism by which simultaneous 
expression of plcR and atxA is inhibitory for B. anthracis sporulation in not understood.  
 Clearly, potential links between development and virulence gene expression in other 
bacteria are worthy of exploration.  With the advent of methods such as RNA-seq and Tn-
seq, facile identification of genes required for bacterial growth and adaptation to different 
environments is possible (115, 167).  These methods could help elucidate common 
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regulators within a species of pathogenic bacteria involved in the control of survival within 
and outside the host.  In addition, using methods like RNA-seq and Tn-seq on B. anthracis 
grown in toxin-inducing versus sporulation conditions could help define additional factors 
that are part of the regulatory network governing atxA expression in each culture condition.   
 
Concluding remarks 
 Regulation of atxA is the subject of investigation by several laboratories with the 
main focus of identifying signals and trans-acting factors responsible for atxA-regulated 
anthrax toxin and capsule production.  My work is the first to demonstrate that AtxA is not 
only a master virulence regulator of the anthrax toxins and capsule, but also modulates 
spore development.  This work demonstrates that B. anthracis senses and responds to its 
local environment by controlling the expression level of atxA using different culture 
condition-dependent regulators (AbrB and atxA repressor protein(s); Fig. 6-1). I showed 
that a trans-acting factor(s) other than AbrB, the atxA repressor protein(s), binds specifically 
to the atxA promoter region and negatively controls transcription.  Furthermore, mutation of 
the repressor binding site results in a significant sporulation defect that is atxA- and pXO2-
61-dependent.  These results suggest that B. anthracis has developed a control mechanism 
that involves AtxA regulation of pXO2-61 as an adaptive measure for continued growth 
within or outside the host environment.  Finally, my data demonstrate that pXO2 negatively 
impacts AtxA protein levels in specific growth conditions and affects anthrax toxin 
production independent of atxA.  These results demonstrate the importance of using a 
genetically complete B. anthracis strain to determine all the regulatory factors controlling 
atxA and toxin gene expression.  Overall, this work expands on the complex regulatory 
networks governing control of atxA and demonstrates the impact of AtxA expression on B. 
anthracis pathogenesis and development.    
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